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The Host Inflammatory Response to a Xenograft Arterial Bypass in a Rabbit Model
Director: David T. Cheung, Ph.D. ^  , C ,
Cardiovascular disease is the leading cause of death in the United States. In a six year 
period, 12.9 million people were diagnosed with coronary heart disease with 515,204 
deaths. When non-invasive treatments are insufficient, coronary bypass surgery is 
necessary. Many graft options are available but not all are suitable as coronary bypass 
grafts.
This study was designed to evaluate the effect of the host inflammatory response toward 
the Corograft xenograft conduit material implanted in the arterial circulation. The 
rabbit model developed is useful for the evaluation of small-diameter biological grafts 
when implanted into the abdominal aorta, and the inflammatory response could be 
increased via hypercholesterolemia or decreased via anti-inflammatory drug treatments.
Normal diet rabbits survive the surgery, maintain patent grafts for up to 6 months which 
are recolonized by host eells. Hypercholesterolemic rabbits had an elevated post­
operative mortality and aneurysm formation was seen in several rabbits, which was 
attributed to hypercholesterolemia. Macrophages are increased, and can secrete matrix 
degrading enzymes, leading to an increased inflammatory response leading to observed 
aneurysm formation.
These grafts elicit a chronic-type inflammatory response allowing this model to be used 
to study the effect of anti-inflammatory drugs. Grafts from drug-treatment samples were 
partially recolonized by host cells and no aneurysm development was seen in any of these 
samples. Both Indomethacin and Etidronate reduced overall macrophage numbers 
compared to saline controls while the humoral response was not reduced.
These data suggest that macrophages, as part of an inflammatory response, may play a 
role in vascular graft failure, and anti-inflammatory treatments reduce the host response 
toward the graft material. This indicates that anti-inflammatory treatments after bypass 
grafting could be important in the long-term survival of grafts in the clinical setting. 
These data could also lead to further modifications of the original graft material during 
production, leading to a product with superior resistance to inflammatory degradation.
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Two roads diverged in a yellow wood. 
And sorry I could not travel both 
And still be one traveler, long I stood 
And looked down one as far as I could 
To where it bent in the undergrowth;
The Road Not Taken 
-Robert Frost-
In leaves no step had trodden black.
Oh, I kept the first for another day!
Yet knowing how way leads on to way, 
I doubted if  I should ever come back.
Then took the other, as just as fair.
And having perhaps the better claim. 
Because it was grassy and wanted wear; 
Though the passing there 
Had worn them really about the same. 
And both that morning equally lay
I shall be telling this with a sigh 
Somewhere ages and ages hence: 
Two roads diverged in a wood, and I 
I took the one less traveled by.
And that has made all the difference.
xm
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Background 
Cardiovascular and Coronary Heart Disease
Cardiovascular disease (CVD) has been the primary cause o f death in the United 
States since 1900 and has killed more people than the next five causes of death combined 
(cancer, chronic lower respiratory diseases, accidents, diabetes, influenza and 
pneumonia) Between 1988 and 1994, an estimated 62 million people in the United 
States were diagnosed with some form of cardiovascular disease, and of these 12.9 
million people were diagnosed with eoronary heart disease (CHD) with 515,204 deaths 
attributed to CHD This corresponds to an average total (direct and indirect) cost of 
$21.7 billion per year for eoronary heart disease. In 2000 alone, interventions to treat 
CHD ineluded 519,000 coronary artery bypass grafting (CABG) surgeries performed in 
314,000 patients; 561,000 percutaneous transluminal coronary angioplasty (PTCA) 
interventions in 547,000 patients; 456,000 stenting procedures; and 2,401,000 other 
procedures which include valve replacements, open heart surgeries, paeemakers, 
endarterectomies, defibrillators, and cardiac catheterizations ^
A variety of factors contribute to the development of CVD, including but not 
limited to; diet, health status, genetic predisposition, level of activity, smoking, and 
obesity. If the condition is not advanced to the point of needing surgical intervention, 
patients can be treated with medications, encouraged to quit smoking, exercise more, and 
educated in ways to improve their diet and control diabetes. If medication, diet and 
exercise are insuffieient in controlling the progression of the disease, then more 
aggressive treatments are available. Depending on the severity of the condition, catheter- 
based coronary revascularization therapies such as percutaneous transluminal coronary
Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.
angioplasty, coronary arthrectomy, laser coronary angioplasty, and coronary stenting 
have proven to be highly effective in a selected population, but restenosis has been a 
common complication with these procedures
In cases where further intervention is necessary by-pass surgery (also CABG or 
Coronary Artery Bypass Grafting) is performed. During coronary artery bypass grafting, 
a blockage or stenosis within the coronary artery(s) is bypassed using an autologous 
small-diameter arterial or venous conduit. This serves to immediately improve blood 
flow to under-perfused areas of the heart, relieve angina, and prevent myocardial 
infarction.
Coronary Graft Options: Advantages, Disadvantages and Limitations
Vascular grafts represent a significant percentage of all the medical device 
implantations performed worldwide and have clinical applications in peripheral 
vascular surgery, arterio-venous shunt construction and coronary artery 
revascularizations. The choice of conduit is important for the outcome of a coronary 
artery bypass graft surgery (CABG), and graft patency is associated with an uneventful 
post-operative recovery and long-term patient survival The determination of patency is 
based upon conduit type (arterial or venous) and the location of the graft insertion (which 
coronary artery) into the coronary circulation, but regardless of location and graft type, a 
high average flow has be used as an indication of a viable patent graft  ̂(Table 1: Mean 
Flow).
Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.
Table 1: Flow readings were recorded during coronary artery bypass surgeries using a 
Transonic Flow Probe. The normal flow readings shown are for 85% of all measured 
cases, and normal flow is given for each graft type and position. Normal coronary flow 
(left and right) is approximately 4% of the cardiac output, or about 225ml/min for a 
5L/min cardiac output  ̂and is split between the right and left coronary branches.
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Table 1: Mean Flow of Arterial and Venous Bypass Grafts
Mean Flow Readings through Grafts during Surgery*
Graft Location Normal Flow Questionable flow Obstructed
LIMA to  LAD >27 ml/min 27  to 5 ml/min
Flow le ss  th an  
5 ml/min
RIMA to  RCA >26 ml/min 26 to 5 ml/min
SVG to  RCA >29 ml/min 29 to 5 ml/min
SV G  to  DIAG >21 ml/min 21 to 5 ml/min
SV G  to  0 M 1 /0 M 2 >29 ml/min 29 to 5 ml/min
SVG to  PDA >24 ml/min 24  to 5 ml/min
SVG to  CX >48 ml/min 48 to 5 ml/min
*Adapted from Transonic Systems, 2002
The Left and/or Right Intemal Mammary Arteries are dissected from the chest wall and 
direetly grafted to a coronary artery. Saphenous Vein Grafts are harvested from the leg, 
reversed and grafted from the ascending aorta (proximal) to the coronary artery (distal). 
LIMA - Left Intemal Mammary Artery, RIM A - Right Intemal Mammary Artery, SVG - 
Saphenous Vein Graft, DIAG - Diagonal, OM - Oblique Marginal, PDA - Posterior 
Descending Artery, CX - Circumflex Artery, LAD - Left Anterior Descending, RCA - 
Right Coronary Artery
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Vascular grafts: Clinical and Experimental
The available graft options, either autologous or non-autologous, possess one or 
more of the charaeteristies described for an ‘ideal’ graft These include 
bioeompatibility, lack of chemical reactivity, low thrombogenicity, porosity, cost, 
sterility and no leaching of processing chemicals. The ideal physical characteristics for 
grafts include: infection resistance, flexibility, resistance to kinking and compression, 
stretch, size range, tensile and shear strength, resistance to arterial pressure, and 
compliance. While several types of grafts are available, autologous grafts are the first 
choice. Problems arise when patients return for a re-operation for failed grafts or have 
pre-existing vascular disease and no autologous conduits are available which is the case 
for 15% of patients returning for a re-operation In these cases, suitable autologous 
conduits may not be available, and other options must be explored. These options will be 
described in the following paragraphs.
Autologous Grafts
Autologous conduits can be either venous (Greater and lesser saphenous veins, 
cephalic and basilic veins)  ̂or arterial (Intemal thoracic, right gastroepiploic, inferior 
epigastric, radial, splenic, gastroduodenal, left gastric, and intercostal) These vessels 
are harvested as part of the revascularization procedure and can be an additional source of 
morbidity with associated risks and complications. The intemal thoracic artery (ITA, 
also intemal mammary artery or IMA) and greater saphenous veins are the first and 
second choices for small diameter conduits used in revascularizations The other 
choices are less commonly used.
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The ITA has a 90% patency at 10 years when grafted to the left anterior 
descending artery (LAD) compared with a 40-50% patency for venous grafts An 
estimated 10-15% of all vein grafts occlude within the first year, after which the failure 
rate is estimated at 1-2% for years 1-6 years, and 4% per year for years 6-10 Of these, 
30% of vein grafts require re-intervention within two years due to significant stenosis due 
to intimal hyperplasia Within 10 years, 30-40% of the re-vascularizations performed 
using autologous conduits are occluded due to atherosclerosis or stenosis secondary to 
atherosclerosis, and of the remaining 60-70% only half are firee of significant amounts of 
stenosis
Intimal hyperplasia is the most common cause of graft failure when autologous 
vein is used for peripheral or coronary bypass surgeries, accoimting for 30 to 50% of all 
graft failures , The majority of vein grafts placed in the arterial circulation develop 
intimal hyperplasia within 6 weeks of implantation, which has been attributed to vessel 
wall ischemia and stress These factors contribute to endothelial dysfunction, an 
important early step in the development of intimal hyperplasia '̂̂ 4 8 ô,2 i 
atherosclerosis Experimentally, autologous venous conduits have been shown to be 
more susceptible to accelerated atherosclerosis and intimal thickening than arterial grafts
23
Non-Autologous Grafts
Synthetic Grafts: Commercially available synthetic grafts include 
polytetrafluoroethylene (PTFE), expanded PTFE (ePTFE, Teflon™), polyethylene 
terephthalate (PET, Dacron™), and polyurethanes. Synthetic conduits are attractive due
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to their physical characteristics and lack of immunogenicity Grafts with an intemal 
diameter of 6mm or greater have worked well under clinical conditions while
grafts with an intemal diameter of 6mm or less have met with a high failure rate due to 
thrombosis, or thrombosis secondary to intimal hyperplasia
PTFE grafts have a satisfactory short-term performance but are susceptible to 
infection and intimal hyperplasia These conduits become re-endothelialized on the 
pannus ingrowth fi'om the anastomosis while thrombus forms in the more central portions 
of the grafts and can become occluded due to pannus sloughing or intimal hyperplasia at 
the anastomic junction PTFE patency rates in the coronary position vary from 59% 
between 1 to 26 months, 64% at one year, and 14% at 45 months, but these grafts rarely 
remain patent in the coronary position
ePTFE is not very hemocompatible/wettable and is not considered suitable for 
applications needing a small diameter graft of 4mm or less One patient is documented 
in literature with a patent 4mm ePTFE aortocoronary graft at 12 years This patient 
had unsuitable greater saphenous veins and intemal mammary arteries.
Dacron grafts have been successful in the coronary position when used as short 
interposition grafts in areas of high flow (ascending aorta and proximal end of the 
coronary artery)
Polyurethane grafts implanted into animals as peripheral grafts resist thrombosis 
and showed a rapid cellular ingrowth with a reduced incidence of intimal hyperplasia at 
the anastomosis However, when 7 different brands of polyurethane grafts were used 
in clinical applications (peripheral implantation or Arterio-venous (AV) fistulae for 
hemodialysis access), these grafts had a high rate of thrombosis, were prone to infection
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and the patency in the femoro-popliteal position varied from 47-59% at 6 months, and as 
AV fistulae from 73% at 6 months to 45-64% at 1 year Aria™ grafts (Thoralon® 
polyurethanurea with silicone) were implanted into 27 patients for compassionate use 
between 1993-96, and at 1 year five patients had died of causes unrelated to the graft 
while the remaining 22 patients were alive and asymptomatic No polyurethane grafts 
are currently approved for human use.
Biological Grafts: Detergent/enzymatically extracted grafts o f human or animal 
origin have met with some success in animal models but are not generally 
available for clinical implantation into humans. Fixed xenogenic grafts such as 
dialdehyde-tanned bovine internal thoracic artery have been used, but this graft was 
deemed unsuitable having a 16% patency rate at 10 months
Umbilical vein conduits (both cryopreserved and glutaradehyde-fixed) are 
potentially an ideal non-autologous conduit source as they are easily obtained and are 
able to withstand arterial pressure and stress due to their circumferential elasticity, 
however they are potentially immunogenic, prone to intimal dissection, and only have a 
50% short-term patency rate which limits their use Umbilical vessels fixed in 
glutaraldehyde have found clinical applications in lower limb revascularization but long 
term patency is poor and they are susceptible to aneurysmatic degeneration
Greater saphenous vein (GSV) grafts are easily obtained (cryopreserved and 
glutaraldehyde-fixed) but immunogenicity is a problem and the cryopreserved grafts have 
a high failure rate due to a deteriorated intima. Patency data indicates these grafts should 
be used with caution and only in cases where no autologous grafts are available GSV 
homografts (12 of 38) had a patency rate o f 31.5% at 1 year. Cryopreserved GSV (61
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grafts in 28 patients) had a 65% patency rate at 2 weeks, while at 12 months none of the 
13 grafts examined were normal. In another study, cryopreserved GSV patency at 7.5 
months was 41% in 19 patients
Biodegradable Polymer Grafts: Biodegradable grafts have been used under 
experimental conditions with some success, but are not yet a viable clinical option.
These grafts consist of a biodegradable scaffold which, depending on the 
composition/ratio of the components, can be ‘programmed’ to degrade within a defined 
period of time. The most common polymers used as scaffold material are poly L-lactic 
acid (PLLA), polyglycolic acid (PGA), poly DL-lactic-co-glycolic acid (PLGA), and 
poly-4-hydroxybutyrate (P4HB) These grafts are usually seeded with cells in vitro 
prior to implantation
General Conclusions on Graft Options
“An excellent substitute conduit for coronary bypass operations that can be taken 
‘off the shelf is certainly the dream of every practicing cardiac surgeon” Since 1942, 
significant efforts have been made to develop alternative grafts for vascular applications 
but have met with limited success Graft options other than autologous conduits are 
experimental, have unsatisfactory patency rates, or both. The major issues linked to 
vascular graft failure include immediate and long-term patency, lack of complete re- 
endothelialization, aneurysmic degeneration, and intimal hyperplasia. The available 
information leads one to conclude that a satisfactory small-diameter blood vessel 
replacement has not yet been found.
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Xenograft Developed at IHI (Corograft ”)
The Corograft™ conduits used in this study were obtained from Philogenesis 
(Monrovia, CA), the company responsible for the commercial production and distribution 
of the conduit material developed at IHI. The conduits used in this study are bovine 
arterial grafts treated by the L-Hydro™ method to reduce antigenicity. The L-Hydro™ 
treatment for biological transplantable tissues (Patent pending) consists of two steps: the 
first step combines a mild extraction of antigens without the use of detergents or digestive 
enzymes and the masking of unextracted antigens by a polyglycol in conjunction with a 
mild chemical oxidation under physical conditions that protect the extracellular 
components (such as collagen and elastin), and as a second step the incorporation of a 
common anti-inflammatory agent (equivalent to aspirin) and an anti-thrombotic agent 
(equivalent to heparin). The conduits are then lyophilized prior to being gas-phase 
sterilized (D-Hydro™).
These conduits have been implanted in a sheep model into both a peripheral 
(carotid) and coronary position and compared to autologous venous conduits. When 
implanted as a coronary bypass (ascending or descending aorta to LAD), Corograft™ 
conduits (less than 4mm ID and more than 10cm in length) showed excellent patency 
rates at five or more months. When examined histologically, the implants were readily re­
colonized by host cells in vivo and showed a complete endothelial-like covering of the 
lumen with smooth muscle cells in the media of the arterial graft wall. When implanted 
in the carotid artery of sheep, complete endothelialization occurred within 3 months post- 
operatively. No evidence of thrombosis, stenosis or aneurysm was seen in these studies.
10
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These conduits have several advantages including biocompatibility, off-the-shelf 
availability, absence of toxic cross-linking agents (glutaraldehyde or formaldehyde), 
room temperature storage, simplified shipping, and no co-morbidity associated with 
autologous vessel harvest. The graft material is easy to handle and use, can be tailored to 
the particular application, and takes a suture well without tearing. These technologies 
have been applied to valves with promising results Although the Corograft^” implant 
studies in sheep have shown promising results, the exact role the anti-inflammatory 
strategy in the treatment of the graft has not been established. The optimum dosage for 
the anti-inflammatory agents used has also not been determined.
In order to study the role of the host inflammatory response to a xenograft arterial 
bypass, three questions needed to be answered: 1) Which animal models and graft 
materials are most appropriate, so that the graft remains patent for an extended period of 
time? 2) If the original hypothesis that inflammation contributes significantly to the 
failure of a xenograft implants is true, can we the chose a model to study the role of 
increased inflammation on the implant? 3) Can we find alternate ways of decreasing the 
inflammatory response toward the graft? Three sets of experiments were designed to 
answer of these questions: 1) a rabbit model with a xenograft implanted in the abdominal 
aorta was studied, 2) inflammation was enhanced by diet-indueed hypercholesterolemia 
to see if this accelerated the failure of the graft, and 3) inflammation was suppressed by 
the administration of anti-inflammatory agents to see if graft durability eould be 
improved. Eaeh of these experiments will be addressed in separate chapters.
II
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Chapter I 
Development of the Animal model
Introduction
Choice of Animal Model
Many issues must be taken into consideration vî hen choosing an animal model for 
vascular graft testing. These may include length and size of the graft which will dictate 
the anatomical locations available for implantation. Composition and size of the graft 
(e.g. biological vs. synthetic) may also play an important role in site selection (e.g. aorta 
vs. femoral vs. coronary) as well as animal model used (large vs. small). The coagulation 
and fibrinolytic characteristics of the individual models must be considered and 
compared to the human system. Other issues may include availability, human perception 
(e.g. using a dog model vs. sheep model), housing and nutritional requirements, body 
size, etc. Animal models used in the past to evaluate vascular grafts include calf, 
primate, pig, sheep, dog, rabbit, rat, and mouse, each with its’ own advantages and 
disadvantages.
Another important consideration in evaluating models for vascular grafts is the 
dynamics of re-endothelialization. The majority of the animal models will spontaneously 
re-endothelialize (with exception of the dog), which is in direct contrast with the human 
system Re-endothelization in humans is usually limited to a distance of ~ 1cm from 
the anastomosis and appears to correspond to the maximal distance of pannus 
ingrowth/anastomotic hyperplasia.
12
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Rabbit Model
The rabbit model has been used extensively for the in vivo evaluation of small­
bore (less than 6mm) vascular grafts The tbrombogenic properties of rabbit blood 
are similar to that of bumans as are the tbromboplastic and fibrinolytic properties of 
rabbit arteries making the rabbit an ideal model for experimental small-diameter 
vascular graft studies. Furthermore, the ease of animal handling, size and cost 
effectiveness make this model attractive. Their low cost makes them economical in 
studies requiring a larger sample size and their small size allows for easy handling and 
boarding. The main disadvantage is their smaller size, necessitating magnification during 
surgery and the use of microsurgical techniques and instruments.
Surgical Model - Location of Implantation
The location of graft implantation depends on the graft to be tested, size o f the 
graft, and other issues such as arterial vs. venous conditions (high vs. low flow).
Common sites of arterial implantation in the various animal models include the carotid 
arteries, as a coronary bypass, the thoracic aorta, the abdominal aorta, as well as the iliac 
and femoral arteries. In a rabbit model, several sites are have been used for for graft 
implantation studies; the carotid artery, the iliac artery, the femoral artery, thoracic aorta, 
and the abdominal aorta.
Many studies have used the rabbit model to evaluate small diameter grafts, but the 
grafts were placed into the carotid position. The carotid position in rabbits has been used 
in the past to evaluate the behavior of autologous vein grafts under both normal and 
atherosclerotic conditions However, this position is not suitable for the
13
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evaluation of a 2-3mm vascular graft due to the size mismatch between the carotid artery 
and the graft. In the rabbit the thoracic and abdominal aortae fall into this size category.
Therefore, the abdominal aorta was chosen in this study because the graft would 
be under arterial pressure, the diameter of the aorta more closely matches the diameter of 
a human coronary artery, and the flow is similar to bypass graft flow conditions. The site 
is also easy to access (compare to the thoracic aorta), the surgery is less invasive than the 
thoracic position, does not require active ventilation, and several studies had been done 
implanting vascular grafts into this position 46.48,49,55,56̂  course of the study,
modifications in the surgical protocol were made to increase operative and post-operative 
survival as well as decreasing the incidence of post-operative paralysis, a common 
occurrence in surgery on the abdominal aorta.
Specific Aim: To develop an animal model in which the Corograft^" conduit can be 
implanted, remain patent long-term, and allow for the study of the host 
inflammatory response toward the graft material under varied conditions.
Rationale
With an increasing number of bypass grafts and re-operations being performed 
each year, there is an urgent need to develop an alternative to the currently available 
coronary graft options. Autologous conduits as well as synthetic and biological options 
explored to this point have all fallen short of the optimal outcome, a disease-free, fully- 
integrated conduit. The key role of inflammation in the failure of both autologous and 
non-autologous options is finally being acknowledged, though much work still needs to
14
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be done to address this issue. To these ends, a model was developed in which the graft 
material could be implanted and the inflammatory response could be increased or 
decreased as desired.
Experimental design
The pilot group consisted of 11 rabbits in which the surgical protocol was 
optimized by the addition of an end-to-end anastomosis, systemic hypothermia and 
supplemented Lactated Ringers solution. This protocol was then used to implant the graft 
into an additional 54 rabbits in two experimental groups, 26 rabbits in diet group and 28 
in the drug groups. In the diet group, the graft performance was evaluated out to 6 
months and to 2 months in the drug groups.
15
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Materials and Methods
Animal Source and Care
Female New Zealand White rabbits (weighing ~3-4kg) were purchased from 
Westem Oregon Rabbit Company (Philomath, OR, USA) and allowed to acclimate for at 
least 7-14 days before initiating any procedures. Rabbits had access to normal rabbit 
chow and water ad libitum through out the duration of the study. Average room 
temperature was 63°F (17-18°C), with a 12hr day/night cycle and 10-12 air changes/hr. 
All animals appeared clinically normal throughout the quarantine period and no other 
pathogen testing was done.
All animals were cared for in accordance with the ‘‘Principles o f  Laboratory 
Animal Care ” formulated by the National Society of Medical Research and the “Guide 
for the Care and Use o f Laboratory Animals ” prepared by the Institute of Animal 
Resources, National Research council, and published by the National Academy Press, 
revised 1996. The use of the animals for this project was reviewed and approved by the 
Institutional Animal Care and Use Committee (lACUC) of The University of Montana. 
The submitted protocol also included criteria for analgesia and euthanasia.
Preoperative Preparation
Rabbits were sedated with an intramuscular dose of ketamine (50mg/kg), the 
abdominal region shaved, and the rabbit placed in a dorsal recumbent position on a 
heating pad (heating pad was off during the hypothermic phase of the surgery). 
Anesthesia was induced and maintained with 1.5-2% Isoflurane/Oxygen mixture 
administered via a ventilator/anesthesia delivery system (North American Drager,
16
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Telford, PA, USA or Isotec 4, Surgivet/Anesco Veterinary Surgical Products, Waukesha, 
WI, USA), and the level of isoflurane was adjusted as needed to keep the animal 
sufficiently anesthetized, as evaluated by ear pinch or any evidence of discomfort. The 
chest cavity was not opened allowing for passive, spontaneous ventilation by the animal 
The core temperature was monitored with a rectal temperature probe and 
electrocardiographic leads were attached so the heart rate could be monitored. Icepacks 
were placed around and between the hind-legs and along the lower flanks. An intra­
venous cannula (22 gauge) was introduced into the marginal ear vein and cold (4°C) 
supplemented Lactated Ringer’s Solution was given initiating the hypothermic phase of 
the surgery. The supplemented Lactated Ringer’s solution contained per liter: 20ml 
sodium bicarbonate (84mg/ml and 50mEq/50ml, American Pharmaceutical Partners, Inc. 
Los Angeles, CA, USA), 50ml of 20% mannitol solution and 0.5ml dexamethasone 
sodium phosphate (4mg/ml, American Regent Laboratories, Shirley, NY, USA).
Surgical Protocol
After sterile draping, a midline laparotomy was performed. The skin was 
retracted with traction sutures and the intestines were displaced to the right side and 
wrapped in laparotomy sponges moistened with cold sterile saline. Isolation of the 
abdominal aorta from the surrounding tissues from below the left renal artery to the iliac 
bifurcation was performed meticulously to avoid accidental injury to the inferior vena 
cava and its branches. Care was taken to identify all aortic branches along the entire 
circumference. If feasible, anastomotic sites were planned to avoid cutting of the large 
dorsal aortic branches. Once all dissection was completed, one ml of heparin was
17
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administered i.v. (1000 USP units/ml, American Pharmaceutical Partners, Inc., Los 
Angeles, CA, USA) and if necessary, further cooling of the animal was achieved by using 
sterile saline slush applied directly into the abdominal cavity and to the laparotomy 
sponge covering the intestines.
When the rectal temperature of the animal reached 34.5°C, the ice packs and the 
saline slush were removed as the temperature continued to drop without additional 
cooling. The cold supplemented Lactated Ringer’s solution was exchanged for warm 
(37°C). Also, warm packs were placed next to the rabbit under the sterile draping and the 
heating pad under the rabbit was switched on to start the re-warming phase of the 
procedure initiating the re-warming period of the surgery.
Dorsal aortic branches within the previously prepared aortic segment were clipped 
and cut. The aorta was occluded proximally and distally with micro-surgical vascular 
clamps (MORIA 200/A, Angled, 30mm. Fine Science Tools, Inc. Foster City, CA, USA) 
placed below the left renal artery and above the inferior mesenteric artery. And keeping 
in mind the elastic recoil of the vessel, the aorta was cut approximately 1 cm from each 
clamp to avoid space issues.
All animals had a Corograft™ (~3-4mm ID x ~4cm minimum) previously re­
hydrated in heparinized saline, implanted into the infrarenal abdominal aorta. An end-to- 
end anastomosis (distal then proximal) was performed with a continuous single 8/0 
Prolene suture (Polypropylene, Ethicon, Inc., Somerville, NJ, USA). Before tying the 
suture for the proximal anastomosis, the distal vascular clamp was removed to flush air 
from the graft by filling the graft with blood to avoid an air embolism. After tying the
18
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suture, the proximal vascular clamp was removed and additional 8/0 Prolene suture used 
(as needed) to control anastomotic or graft bleeding.
The intestines were returned to the abdominal cavity and repeatedly lavaged with 
warm sterile saline to achieve appropriate re-warming of the animal. When the rectal 
temperature of the rabbit reached 36.5°C to 37.5°C, the saline was removed and the 
laparotomy closed in two layers with 3/0 Vicryl (Polygalactin 910, Ethicon, Inc., 
Somerville, NJ, USA). The supplemented Lactated Ringer’s solution was discontinued, 
with a total amount of 100-150ml having been administered for both the cold and warm 
solutions. When the animal was re-warmed to physiological temperature (101-104°F/38- 
40°C) and movement was seen in the hind-limbs, the animal was returned to its’ cage.
Rabbits received 0.2ml flunixin meglumine (50mg/ml, Equileve®, Phoenix 
Scientific, Inc., St. Joseph, MO, USA) i.m. as an analgesic immediately after surgery, and
0.2ml i.m. flunixin meglumine BID for 4 days post-operatively. All rabbits were 
monitored for neurologic or ischemic complications of the hind limbs throughout the 
study. No antibiotic prophylaxis, platelet aggregation inhibitors nor anticoagulants were 
used postoperatively.
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Results
Pilot group
The pilot group consisted of 11 rabbits in which the surgical, anesthesia, and 
hypothermia techniques were optimized. Initially, the graft material was implanted into 
the carotid position in 3 rabbits, but this was discontinued. All subsequent rabbits had the 
conduit implanted into the abdominal position. The graft was implanted into the 
abdominal position without hypothermia in four rabbits, all of which died during surgery. 
One died due to excessive cross-clamp time, the other due to anesthetic complications, 
the remaining two rabbits due to unknown causes. Two rabbits underwent surgery with 
systemic hypothermia, but died during the procedure. Of the two that survived the 
surgery, one died the following day and the other was euthanized at 22 days.
Incorporation of systemic hypothermia, modified Lactated Ringers solution and 
short cross-clamp time resulted in greater graft patency. All grafts implanted into normal 
rabbits were patent at surgery (13 of 13), and ten were patent at sacrifice at 2 (n=3), 4 
(n=4) and 6 months (n=3). Of the additional three, one rabbit died at 5-i- months due to 
intestinal ischemia and two rabbits were euthanized due to post-operative complications 
and were excluded from the study. For the cholesterol-diet rabbits all 13 grafts were 
patent at surgery, and with the exception of the 2 month sample, the grafts harvested from 
the cholesterol-diet rabbits were post-mortem samples and patency could not be assessed. 
In the drug treatment groups, 28 of 28 grafts were patent at surgery and 15 at sacrifice. 
The additional 13 rabbits died or were sacrificed due to peri-operative or post-operative 
complications unrelated to graft patency. Of these, 2 rabbits developed paraplegia.
These results are summarized in table 2.
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Table 2: Except for three rabbits in the pilot group which had the graft implanted in the 
carotid position, all other rabbits had the 3-4mm diameter x 4cm Corograft™ xenograft 
conduit implanted into the abdominal aorta distal to the kidneys but proximal to the iliac 
biftircation. The Pilot Group includes rabbits used to develop the surgical model in 
which the operative variables (hypothermic and cross-clamp time) were optimized. The 
Normal Diet group includes all rabbits fed a normal rabbit chow, while the Cholesterol 
Diet group includes all rabbits fed commercially available rabbit chow supplemented 
with 1% cholesterol. The Drug Treated group includes rabbits in which saline, 
Indomethacin or Etidronate were administered suhcutaneously during the duration of the 
study. The total number of rabbits implanted with a graft in each group are listed in the # 
Operated column. The total number of rabbits included in each group are listed in the # 
Valid column, and represent animals sacrificed when scheduled. The remainder of the 
animals were excluded due to death, operative or post-operative complications unrelated 
to the graft.
21
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Table 2: Valid Animals
Group # Operated # Valid # Excluded
Pilot Study 11 NA NA
Normal Diet 13 10 3
Cholesterol Diet 13 1 12
Drug Treated 28 15 13
Total 65 26 28
NA - Not Applica ?le
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Discussion
The implantation of small-diameter vaseular grafts, either of human or synthetie 
origin, is performed daily in current medical practice and the number of vascular grafts 
implanted each year numbers over one million throughout the world. In the USA alone, 
571,000 coronary artery bypass grafts were performed in 1999 Autologous arteries 
and veins still represent the best treatment options, however pre-existing vascular 
diseases or previous cardiovascular procedures emphasize the need for a safe, durable 
and long-term altemative graft of an acceptable diameter.
Rabbit Model
This project was started due to an observation that the Corograft' '̂  ̂conduit had not 
been tested in a disease model, and that the long-term outeome of this graft under 
eonditions of atherosclerosis would provide valuable information. This study would have 
been prohibitively expensive in the sheep model used at the time to evaluate these grafts 
in vivo. After reviewing the available literature the rabbit was chosen as a model due to 
the amount of information in the literature using this model to evaluate small diameter 
grafts (less than 6mm) and that inflammation could be increased or decreased in order to 
further evaluated the role of inflammation on the host response toward the Corograft™ in 
later portions of this study.
Abdominal Aorta
Initially, the graft material was implanted into the carotid position, but this was 
discontinued for several reasons. There was a large size mismatch between the carotid
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artery (~l-2mm) and the graft material available at the time (3-4mm). The carotid 
position was difficult to access due to limited space, and close proximity of the jugular 
vein made it difficult to isolate the carotid without damage to the vein. Also, there was 
no way to monitor the patency of the graft material during the long term study. This 
approach was discontinued and the alternate implantation site of the abdominal aorta used 
instead.
The abdominal aorta was chosen as it approximates the size and arterial 
conditions of a human coronary artery (superior to implantation into the carotid position 
of rabbits). The blood flow through the abdominal aorta proximal to the iliac bifurcation 
for a rabbit is 65.1 ± 3.2ml/min compared to ~225ml/min (split between the left and 
right coronary arteries) through the coronary circulation in humans ^ This flow falls into 
the normal flow range of a coronary graft from either an internal thoracic or the 
ascending aorta to any coronary artery branch An additional advantage of this model 
is that if the graft occludes post-operatively, hind-limb paralysis results and serves as an 
indicator of patency throughout the study. This is a separate issue from spinal chord 
ischemia which can occur as a complication associated with surgery involving the 
thoracic and abdominal aorta, and also results in hind-limb paralysis in the rabbit model
57
Hypothermia and Cross-Clamp Time
The basic surgical protocol put forth by Nordestgaard et al. was explored as a 
model of graft implantation into the abdominal aorta of rabbits. Initially, several cases of 
postoperative paraplegia in rabbits implanted with a Corograft™ conduit led us to explore
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reasons for these complications and a literature review indicated that normothermic 
ischemic injury of the spinal chord had been previously shown to result in paraplegia 
48 , 57,60  application of controlled mild systemic hypothermia (32-34°C) to
this surgical model. Mild hypothermia offers significant protection from ischemic spinal 
chord injury resulting in increased recovery of motor function and reduces 
metabolic demands during the ischemic period
However hypothermia alone might be insufficient to avoid paraplegia when the 
cross-clamp time was in excess of 20 minutes For this reason the supplemented 
Lactated Ringers solution was incorporated into the methodology. This was based in part 
on a study by Ueno et.al. in which they occluded the abdominal aorta of rabbits for 45 
minutes and also infused Lactated Ringers solution alone or containing 
methylprednisolone (MP), MP+Mannitol, or MP+mannitol+vitamins E and C, and found 
no incidence of paraplegia in the group in which the complete solution was administered. 
The Lactated Ringers solution used in this study was supplemented with sodium 
bicarbonate, mannitol and dexamethasone sodium phosphate in an effort to further reduce 
the incidence of paralysis due to spinal ischemia. This solution is similar to cardioplegia 
formulations used during bypass surgery to protect the heart from ischemic damage and 
would control metabolic acidosis (sodium bicarbonate), ischemic cellular swelling 
(mannitol) and ischemia-reperfusion injury induced inflammation (dexamethasone).
The pilot group indicated that a cross-clamp time in excess of 30 minutes under 
normothermic or mild hypothermic conditions contributed to a high rate of postoperative 
paralysis in rabbits regardless of graft patency. This observation was supported by the 
study of Tolwani et.al. where mild hypothermia and a mean cross-clamp time of 30
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minutes or less resulted in a 3% incidence of paraplegia, while without hypothermia the 
incidence of paraplegia was 100%. This observation is also supported by Nordestgaards’ 
study where grafted rabbits had a high incidence of paralysis which could possibly be 
attributed to their cross-clamp time. Their cross-clamp time varied from 20-50 minutes 
under normothermic conditions and of 42 rabbits implanted with 2 and 3mm grafts, 18 
developed paralysis during their study (42%).
Anastomosis
An end-to-side type of anastomosis was initially performed which would simulate 
grafting in humans bypassing an occlusion or stenosis in a coronary artery, with the 
intention of sparing the spinal aortic branches from the abdominal aorta by ligating the 
aorta between the anastomoses. Due to the technical performance of an end-to-side 
anastomosis, a longer cross-clamping time and the possibility of anastomotic occlusion 
by thrombus extension from the point of the tied native aorta, this approach was 
discontinued. Instead, an end-to-end anastomosis was performed and every possible 
effort was made to position the graft to avoid the clipping and cutting of large spinal 
branches. A continuous suture pattem was chosen over an interrupted pattem in order to 
minimize the cross-clamp time. An interrupted suture pattem is more commonly used 
with smaller grafts under conditions where there is a possibility of producing a stenosis at 
the anastomosis.
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Graft Length
The general criteria used by cardiac surgeons to evaluate an experimental vascular 
graft for possible use as a coronary bypass in bumans are: 4mm diameter by 4cm length 
with at least 4 months patency (Personal Communication, Dr. C. M. G. Duran). When 
testing grafts in a rabbit model many published studies implanted grafts of ~ 1cm which 
appears insufficient to adequately evaluate re-endotbelialization, which in bumans can 
reach 1cm at each anastomosis due to pannus ingrowth. For this reason the graft length 
implanted in this study was 3-4mm in diameter by ~4em in length in which patency was 
confirmed out to 6 months.
Graft Performance: Corograft™ vs. Other Graft Options
Of the 58 rabbits implanted with a graft in the abdominal position, all grafts were 
patent at surgery, giving a 100% immediate patency. Of the 26 valid animals (normal 
diet n=l 1, cholesterol diet n=l, drug groups n=15), one possible case of thrombosis (Smo 
death) gives a patency rate of 96%. Six rabbits of 58 developed paraplegia during this 
study in the immediate post-operative period, giving a paraplegia rate of 10.3%. The 
grafts were examined in all cases of post-operative paralysis, and none of the grafts were 
thrombosed, suggesting that ischemic injury to the spinal chord might be the cause. 
Patency could not be assessed due to post-mortem clotting for grafts removed from 
rabbits found dead, but one death at 5 months due to intestinal ischemia might have been 
due to thrombosis.
By comparison, Nordestgaard et.al. implanted polytetrafluoroethylene eonduits 
(2 or 3mm by 1cm) into the abdominal position of rabbits with a pateney rate of 24% for
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2mm grafts and 72% for 3mm grafts. Of the 17 rabbits with 2mm grafts, 12 were killed 
or died within the first 7 days due to graft thrombosis, while 4 of the 5 survivors had 
patent grafts at the end of 3 months. Of the 25 rabbits they grafted with 3mm grafts, 19 
grafts were patent at 1 week and 18 were patent at 3 months. Lee et.al. implanted 3mm x 
35mm PFTE grafts into the abdominal aorta under normothermic conditions. The 
grafts were harvested at 7 and 42 days (5 each). They had no instances of thrombosis in 
their study and no cross-clamp information was given.
The patency of PTFE (2mm x 15mm) in the carotid position of rabbits is excellent 
at 2 weeks (89%), after which patency declines to 86% atl6 weeks, and -68% at 32 
weeks compared to 100% patency for autologous grafts Sparks et.al. implanted PTFE 
grafts (2mm x 10mm) into the carotid position and evaluated patency at 7,14 and 21 days 
(each n=5). Patency was 40% at 7 and 14 days with a patency of 20 % at 21 days 
When PTFE or poljairethane grafts (1.5mm x 10mm) grafts were implanted into the 
carotid position of rabbits by van der Lei et.al, no improvements in patency or 
thrombosis resistance were seen All polyurethane and PTFE grafts (each 4 of 4) were 
patent at 1 hour, 2 of 4 were patent at 1 day, 1 of 4 at 1 week, while none were patent at 
2, 3 and 6 weeks (each 6 of 6). By comparison, all arterial autografts were patent to 2 
weeks (not done at 3 and 6 weeks).
The differences in patency seen in these published studies could be attributed to 
among other things surgical technique, but they serve to illustrate that the patency of non- 
autologous small diameter grafts in the rabbit model is less than optimal. However, a 
true assessment of patency for these studies may be difficult to determine as only 
successfully grafted animals may have been included in the published study. By
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comparison, the graft used in this study shows excellent patency and thrombosis 
resistance, indicating that performance of this graft material is superior to previously 
published studies where non-autologous grafts were implanted into the circulation of 
rabbits.
Conclusions
Hypothermia in conjunction with the supplemented Lactated Ringers solution and 
strictly observing a cross-clamp time of 30 minutes or less effectively reduced the 
incidence of post-operative paraplegia in this study and contributed to the success of this 
model In addition, the surgical protocol is straight forward in its’ approach and gives 
excellent results allowing for a greater percentage of valid animals, allowing for 
refinement of the study approach and a reduction in the total number of animals needed 
for a given study. When compared to similar studies in which a vascular graft was 
implanted into the abdominal aorta or carotid artery position of rabbits, the graft 
implanted in this study had a 100% immediate patency rate in all study groups using a 3- 
4mm diameter graft with a 4cm length. The longer term patency and thrombosis 
resistance of the Corograft™ is excellent, and exceeds published studies. However, in all 
cases one must remember the rabbit is an animal model and that any findings must 
eventually be verified in humans.
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Chapter II 
The effect of an increased inflammatory response on graft survival 
Introduction 
Inflammation
Within several minutes of injury, the vessels in the area of injury vasodialate (heat 
and redness) and become permeable, leaking fluid (edema) and leukocytes into the 
injured tissue. This leads to the activation of the clotting, kinin, and fibrinolytic cascades. 
Within several hours, neutrophils bind to the activated endothelium, extravasate into the 
surrounding tissues, and actively phagocytize invading organisms and release other 
inflammatory mediators, including M IP-la and -lb (Macrophage Inflammatory Protein), 
which are responsible for attracting monocyte/macrophages into the area. Once present 
the macrophages are also responsible for phagocytosis and the release of further 
inflammatory mediators affecting coagulation, vascular permeability, and leucocyte 
chemotaxis. Eventually the offending stimulus is phagocytized or removed and the 
inflammatory response resolves. If the stimulus is not removed, the inflammatory 
response may proceed into a chronic inflammatory reaction.
Chronic inflammation can follow acute inflammation or can develop 
independently. Chronic inflammation may be a result of persistence of an infectious 
microorganism (e.g. tuberculosis), the presence of foreign bodies (e.g. surgical implants) 
or insoluble particles (e.g. silicosis), a persistent hypersensitive state (e.g. non-infective- 
allergic contact dermatitis, autoimmune-rheumatoid arthritis), or due to an unknown 
cause (e.g. Crohn’s disease) V Chronic inflammation is characterized by the presence of
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an inflammatory infiltrate (macrophages, lymphocytes and plasma cells, not usually 
neutrophils), the formation of granulation tissue, fibrosis, and abnormal tissue 
remodeling. The presence of macrophage giant cells, generated by the fusion of activated 
macrophages, is indicative of an on-going chronic inflammatory reaction, and the type of 
giant cell present can serve as a preliminary indicator of the type of offending stimulus.
Modes of Graft Failure
Implanted grafts are susceptible to failure via several mechanisms including 
thrombosis, intimal hyperplasia, atherosclerosis, and aneurysm. The primary cause of 
graft failure is thrombosis Thrombosis can also occur secondary to intimal 
hyperplasia and atherosclerosis as both are responsible for grafts stenosis which can 
result in thrombosis via the reduction of flow Thrombosis can also be a result of 
atherosclerotic plaque rupture, as the lipid core of an advanced plaque contains a large 
amount of tissue factor that can initiate the coagulation cascade leading to thrombus 
formation Grafts can also fail by aneurysmatic degeneration
Intimal Hyperplasia
First described in 1906 by Carrel and Guthrie intimal hyperplasia can develop 
as a result of mechanical, chemical or immunological injury to a vessel or when vein 
grafts or prosthetic grafts are used  ̂in clinical applications. Intimal hyperplasia is 
characterized by neointimal thickenings composed of smooth muscle cells and 
extracellular matrix which develop between the intemal elastic lamina and endothelium 
(artery) or the endothelium and medial smooth muscle layer (vein). This is accomplished
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by the proliferation of resident vascular smooth muscle cells and may also involve the 
migration of cells from surrounding tissue
While intimal hyperplasia is typically addressed as a pathological manifestation, 
derangement of the normal healing response or as a response to an insult, it does occur 
under normal conditions. It is responsible for the closure of the ductus arteriosus, the 
arterio-venous shunt bypassing the fetal lungs during gestation, allowing normal 
circulation and oxygenation of blood post-natally. It also occurs as a part of the normal 
aging process and is seen as diffuse thickenings in the vasculature or at sites of 
turbulence in the flow of blood at points where vessels branch (often referred to as 
adaptive intimal thickenings).
Intimal hyperplasia appears to be linked to an inflammatory response as an 
infiltration of mononuclear cells and T cells is a common finding. Cytokines from these 
inflammatory cells may be responsible for initiating and supporting the proliferation and 
migration of smooth muscle cells and the deposition of extracellular matrix. Research 
has shown a strong correlation between the severity of the inflammatory response and the 
ultimate severity of the hyperplasia, and reducing the inflammatory response like-wise 
reduces intimal hyperplasia Intimal hyperplasia may also play a role in the 
development of atherosclerosis while hypercholesterolemia increases the 
development of intimal hyperplasia This process also contributes to the failure of 
vascularized organ transplants and venous conduits used as bypass grafts
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Atherosclerosis
Atherosclerosis is primarily a disease of the large arteries and is the most 
significant cause of heart disease and strokes in westernized societies, accounting for 
50% of all deaths Risk factors associated with the development of atherosclerosis 
include high levels of lipoproteins, genetic predisposition, sedentary life-style, obesity, 
and smoking This condition is characterized by the progressive accumulation of 
lipid-laden macrophage-derived foam cells in the arterial wall, proliferation of smooth 
muscle cells and foam cells, and the abnormal deposition of extracellular matrix. The 
apoptosis of foam cells releases the intracellular oxidized lipids into the surrounding 
tissue that ultimately results in the formation of a necrotic lipid pool. These 
atherosclerotic plaques in latter stages of the disease can encroach on the lumen of the 
vessel causing a progressive stenosis. Both the rupture of a plaque releasing the necrotic 
lipid core or the development of an advanced stenosis can lead to thrombosis of the 
affected vessel. Atherosclerosis also affects vascular grafts (both artery and vein) and 
can lead to graft failure directly (by the rupture of an advanced lesion resulting in 
thrombosis) or indirectly (due to plaque formation causing a stenosis which reduces flow, 
leading to thrombosis).
Macrophages play an important role in the development and progression of 
atherosclerosis ’ ’ which can also be considered a chronic inflammatory response ‘ . 
The lesions produced during the evolution o f atherosclerosis are dominated by 
macrophages, and the severity of the disease appears to be linked to the prominence of 
these cells. Activated T cells are also a significant component of atherosclerotic lesions, 
and the presence o f T cells and macrophages suggests that a cell-mediated inflammatory
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response may play a role in atherosclerosis, with the macrophages functioning as antigen 
presenting cells for T cells Using a rat model of diet-induced atherosclerosis, T cell 
infiltration was most significant within two weeks of initiating the hypercholesterolemic 
diet, making up 60%, 29% and 34% of the infiltrating cells in lesions of the superior 
thoracic, inferior thoracic and abdominal aorta, respectively The secretory products of 
macrophages and T cells have been implicated in the cellular responses that occur 
throughout lesion formation For example. Interferon P from activated T cells causes 
smooth muscle cell apoptosis, inhibits collagen synthesis by smooth muscle cells, and 
increases MMP release from foam cells, all which contribute to a reduction in the amount 
of extracellular matrix and increased matrix degradation seen in atherosclerosis ^
Aneurysms
Aneurysm development has also been characterized as a chronic-type 
inflammatory response Four major factors have been implicated in the formation of 
an aneurysmatic lesion: degradation of aortic wall tissue, inflammation and immune 
response, wall stress, and predisposing genetic factors however the initiating stimulus 
for aneurysm formation is yet unclear. The formation of an aneurysm is
characterized by dilation of the affected vessel, remodeling of the vessel wall with 
destruction of elastin and abnormal deposition of collagen, and an extensive chronic 
inflammatory infiltrate of macrophages and T cells with associated elevated 
production of matrix metalloproteases (MMPs)
The inflammatory infiltrate is thought to play a causative role in aneurysm 
formation by stimulating the secretion of MMPs and by releasing cytokines that induce
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the production of MMPs by activated in situ mesenchymal cells and phagocytic cells 
The dilation is often attributed to the loss o f elastic tissue due to breakdown of this 
component by matrix metalloproteases (MMPs) which are increased in human aneurysm 
tissue and animal models of aneurysm Models of aneurysm formation have
shown that attenuating the inflammatory response inhibits further dilation while 
increasing inflammation augments the development Elevated plasma levels o f MMPs 
are also seen in patients with abdominal aortic aneurysms and appear to correlate with 
elevated tissue levels of MMP in affected tissue
The Role of Inflammation in Vascular Diseases
Inflammation has been linked to the development of vascular conditions such as 
intimal hyperplasia atherosclerosis and aneurysm In these conditions there 
is a response involving resident and inflammatory cells, matrix metalloproteases (MMPs) 
and the extracellular matrix, resulting in abnormal matrix remodeling with thirming 
(aneurysm) or excessive/abnormal deposition (atherosclerosis and intimal 
hyperplasia)
Levels of inflammatory markers (especially C-reactive protein (CRP), but also 
IL6 , TNFa and adhesion molecules) have been used as indicators of cardiovascular 
disease and levels correlate well with the severity of the disease and may also be 
predictive of future events CRP level were elevated in Intimal Hyperplasia 
Atherosclerosis Aneurysm indicating an ongoing inflammatory response in 
each of these conditions. CRP levels have also been linked to thrombosis
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Jabs et.al. examined samples o f normal and diseased vessels as well as diseased 
coronary bypass grafts for the presence of CRP. Their results showed the presence of 
CRP protein in 82% of diseased coronary arteries and in 100% of the diseased bypass 
grafts. These observations implicate inflammation in the failure of grafts implanted into 
the circulation.
Since intimal hyperplasia, atherosclerosis, aneurysm and thrombosis have been 
linked to the failure of vascular grafts implanted into the circulation, and in each 
condition an important marker of inflammation is elevated, leading to the hypothesis that 
inflammation plays a key role in vascular graft failure.
Models of Human Disease
Many animal models have been adapted to approximate human vascular disease 
and have been used with great success (e.g. Atherosclerosis; diet-induced without injury 
with injury for advanced lesion formation by balloon or catheter denuding 
Aneurysm formation; CaCb application Elastase perfusion model Intimal 
Hyperplasia; Grafting Injury However, one must always remember that they 
are an artificially created condition that does not spontaneously/normally occur in the 
particular model. Physical and physiological parameters of the model must be carefully 
evaluated and compared to the human system they are to represent.
Increasing Inflammation via Hypercholesterolemia
Inflammation has been linked to the development of atherosclerosis and
previous work with animal models has shown that inflammation and the development of
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atherosclerosis are linked This is supported by observations that endothelial cells 
become activated £ind express adhesion molecules which allow for the binding and 
transmigration of monocytes, and these areas of activated endothelial cells correspond to 
areas of developing atheroma. Once in the vessel media, these macrophages differentiate 
into foam cells and contribute to the development of a chronic-type inflammatory 
response leading to complex lesions involving endothelial cells, macrophages, T 
cells, and smooth muscle cells. In atherosclerosis, macrophage-derived foam cells are 
the main component of lesions and are involved in the development and progression of 
the disease
Published studies suggest that the production of MMPs as well as MMP activity 
are increased by atherosclerosis. In a study by Galis et.al. foam cells isolated from 
rabbit atheroma were shown to produce MMPs constitutively when compared to alveolar 
macrophages isolated from the same animal. Both stimulated and unstimulated foam 
cells synthesized and released MMPs in vitro while alveolar macrophages did not, and 
stimulation caused the foam cells to release additional MMPs Hypercholesterolemia 
has been shown to cause the increased secretion of MMP-2 and -9 in the aortas of 
cholesterol-fed rabbits which has been associated with the formation of abdominal 
aortic aneurysms. MMP-2 production and binding to the aortic matrix has been shown to 
be increased in abdominal aneurysm formation in human samples and circulating levels 
of MMP-9 have been associated with abdominal aortic aneurysms Also partially 
digested fragments o f ECM have been shown to induce an inflammatory response by 
calling in lymphocytes, monocytes and PMNs
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Atherosclerosis is considered the primary cause of aneurysm development in 
humans as atherosclerotic changes were seen in aneurysm tissue, there was an association 
between aneurysm diameter and adventitial inflammation, and hypercholesterolemia 
plays an important role in monocyte/macrophage chemotaxis and activation In 
humans, injury to the media caused by atherosclerosis, hypertension, smoking, genetic 
factors, etc. that damaged the elastic components of the vessel, in conjunction with 
alterations in the elasticity of the aorta due to pulse pressure, were considered critical for 
aneurysmal dilation In a study by Freestone et.al. both hypercholesterolemia and 
adventitial inflammation both played a role in aneurysm development in rabbit vessels.
Specific Aim: To evaluate the role of increased inflammation via an atherogenic diet 
on the xenogenic graft material. 
Rationale
Previous studies have shown that feeding rabbits a diet supplemented with 
cholesterol leads to the development of atherosclerosis 2̂-54,68-70 
atherosclerosis in humans Since hyperlipidemia has been linked to the accelerated 
development of atherosclerosis in prosthetic and vein grafts and atherosclerosis
is considered an inflammatory disease it was hypothesized that by inducing 
atherosclerosis via a hypercholesterolemic diet in the rabbit model described in the 
previous section, the severity of inflammation could he increased towards the Corograft™ 
conduit and the effect of increased inflammation on the vascular graft could be assessed.
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Experimental Design
In this portion of the study, 26 rabbits were divided into two groups. Thirteen 
rabbits were fed a commercially available rabbit chow and thirteen were fed rabbit chow 
containing 1% cholesterol for 3 months prior to surgery. Blood samples were collected 
on a weekly basis and the serum cholesterol levels analyzed. Rabbits fed a cholesterol 
diet had serum cholesterol levels well above normal, while normal diet rabbits showed no 
increase. After 3 months of the diet, grafts were implanted into the abdominal aorta and 
the rabbits continued on the respective diets. The grafts were harvested at 2 ,4  and 6  
months and analyzed by histology and immunohistology. Also, zymograms for MMP 
activity and a Humoral ELISA were performed on surgery and sacrifice serum samples. 
As atherosclerosis is considered an inflammatory disease, the presence of atherosclerotic 
type lesions within the vasculature or the graft material would be used as an indicator of 
increased inflammation. CRP levels were to be analyzed but proved to be prohibitively 
expensive and were not done.
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Materials and Methods
Animal Source and Care
Female New Zealand White rabbits (Oryctolagus cuniculus) were obtained from 
Western Oregon Rabbit Company (Philomath, OR, USA) and were allowed to acclimate 
for at least 14 days before initiating any procedures. Rabbits were fed either normal 
rabbit chow (Laboratory Rabbit Diet HP, #5326, Lab Diet, Richmond, ID, USA) or chow 
with 1% cholesterol added, and water ad libitum throughout the duration of the study. 
Average room temperature was 63°F (17-18°C), with a 12hr day/night cycle and 10-12 
air changes/hr. All animals appeared clinically normal throughout the 14-day quarantine 
period and no other pathogen testing was done. Venous blood samples were collected 
weekly prior to surgery and monthly after surgery for serum cholesterol levels.
Preoperative Preparation
Rabbits were sedated with an intramuscular dose of ketamine (50mg/kg), the 
abdominal region shaved, and the rabbit placed in a dorsal recumbent position on a 
heating pad (heating pad was off during the hypothermic phase of the surgery). 
Anesthesia was induced and maintained with 1.5-2% Isoflurane/Oxygen mixture 
administered via a ventilator/anesthesia delivery system (North American Drager, 
Telford, PA, USA or Isotec 4, Surgivet/Anesco Veterinary Surgical Products, Waukesha, 
WI, USA), and the level of isoflurane was adjusted as needed to keep the animal 
sufficiently anesthetized, as evaluated by ear pinch or any evidence of discomfort. The 
chest cavity was not opened allowing for passive, spontaneous ventilation by the animal 
The core temperature was monitored with a rectal temperature probe and
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electrocardiographic leads were attached so the heart rate could be monitored. Icepacks 
were placed around and between the hind-legs and along the lower flanks. An intra­
venous cannula (22 gauge) was introduced into the marginal ear vein and cold (4°C) 
supplemented Lactated Ringer’s Solution was given initiating the hypothermic phase of 
the surgery. The supplemented Lactated Ringer’s solution contained per liter: 20ml 
sodium bicarbonate (84mg/ml and 50mEq/50ml, American Pharmaceutical Partners, Inc. 
Los Angeles, CA, USA), 50ml of 20% mannitol solution and 0.5ml dexamethasone 
sodium phosphate (4mg/ml, American Regent Laboratories, Shirley, NY, USA).
Surgical Protocol
After sterile draping, a midline laparotomy was performed. The skin was 
retracted with traction sutures and the intestines were displaced to the right side and 
wrapped in laparotomy sponges moistened with cold sterile saline. Isolation of the 
abdominal aorta from the surrounding tissues from below the left renal artery to the iliac 
biftircation was performed meticulously to avoid accidental injury to the inferior vena 
cava and its branches. Care was taken to identify all aortic branches along the entire 
circumference. If feasible, anastomotic sites were planned to avoid cutting of the large 
dorsal aortic branches. Once all dissection was completed, one ml of heparin was 
administered i.v. (1000 USP units/ml, American Pharmaceutical Partners, Inc., Los 
Angeles, CA, USA) and if necessary, further cooling of the animal was achieved by using 
sterile saline slush applied directly into the abdominal cavity and to the laparotomy 
sponge covering the intestines.
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When the rectal temperature of the animal reached 34.5°C, the ice packs and the 
saline slush were removed as the temperature continued to drop without additional 
cooling. The cold supplemented Lactated Ringer’s solution was exchanged for warm 
(37°C). Also, warm packs were placed next to the rabbit under the sterile draping and the 
heating pad under the rabbit was switched on to start the re-warming phase of the 
procedure initiating the re-warming period of the surgery.
Dorsal aortic branches within the previously prepared aortic segment were clipped 
and cut. The aorta was occluded proximally and distally with micro-surgical vascular 
clamps (MORIA 200/A, Angled, 30mm. Fine Science Tools, Inc. Foster City, CA, USA) 
placed below the left renal artery and above the inferior mesenteric artery. And keeping 
in mind the elastic recoil of the vessel, the aorta was cut approximately 1 cm from each 
clamp to avoid space issues.
All animals had a Corograft™ (~3-4mm ID x ~4cm minimum) previously re­
hydrated in heparinized saline, implanted into the inffarenal abdominal aorta. An end-to- 
end anastomosis (distal then proximal) was performed with a continuous single 8 /0  
Prolene suture (Polypropylene, Ethicon, Inc., Somerville, NJ, USA). Before tying the 
suture for the proximal anastomosis, the distal vascular clamp was removed to flush air 
from the graft by filling the graft with blood to avoid an air embolism. After tying the 
suture, the proximal vascular clamp was removed and additional 8/0 Prolene suture used 
(as needed) to control anastomotic or graft bleeding.
The intestines were returned to the abdominal cavity and repeatedly lavaged with 
warm sterile saline to achieve appropriate re-warming of the animal. When the rectal 
temperature of the rabbit reached 36.5°C to 37.5°C, the saline was removed and the
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laparotomy closed in two layers with 3/0 Vicryl (Polygalactin 910, Ethicon, Inc., 
Somerville, NJ, USA). The supplemented Lactated Ringer’s solution was discontinued, 
with a total amount of 100-150ml having been administered for both the cold and warm 
solutions. When the animal was re-warmed to physiological temperature (101-104°F/38- 
40°C) and movement was seen in the hind-limbs, the animal was returned to its’ cage.
Rabbits received 0.2ml flunixin meglumine (50mg/ml, Equileve®, Phoenix 
Scientific, Inc., St. Joseph, MO, USA) i.m. as an analgesic immediately after surgery, and 
0.2ml i.m. flunixin meglumine BID for 4 days post-operatively. All rabbits were 
monitored for neurologic or ischemic complications of the hind limbs throughout the 
study. No antibiotic prophylaxis, platelet aggregation inhibitors nor antieoagulants were 
used postoperatively.
Sacrifice
The animals were sedated and brought to a full surgical plane of anesthesia. The 
abdominal incision was re-opened and the graft dissected from surrounding tissues. Once 
isolated, the rabbits were fully heparinized and then sacrificed. The graft was then 
excised en-bloc and placed into Histo-Choice Tissue Fixative MB (Amresco Inc., Solon, 
Ohio, USA) for a minimum of 24hrs before further processing.
Macroscopic Examination
Excess non-adherent tissue/fat was trimmed from the exterior of the graft and the 
graft was photographed with markers plaeed indicating the suture lines and direction of 
flow. Each graft was evaluated macroscopically for aneurysmatic changes (indicated by
51
Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.
an area of vessel wall ballooning outwards and being of a greater diameter than the 
originally implanted graft), atherosclerotic lesions, thrombus, or any other obvious 
abnormalities.
Histology
Samples (2-3mm) cut from the center of the graft were dehydrated and embedded 
in PolyFin wax (Polysciences, Inc., Warrington, Pennsylvania, USA), sectioned at 5jim, 
and collected on slides coated with poly-L-lysine (Sigma Chemical Co., St. Louis, MO, 
USA) or charged slides (Superfrost® plus, VWR Scientific, West Chester, PA, USA). 
Representative sections were stained with hematoxylin and eosin (H&E) for general 
tissue/cellular morphology, Masson’s Trichrome for collagen and Movat’s Pentachrome 
stain for collagen and elastin.
Immunohistology
Slides for immunohistology were prepared as above. Representative sections 
were stained for a-smooth muscle cell actin (a smooth muscle cell/myofibroblast 
marker), CD3 (pan-T cell antibody) and RAM 11 (rabbit macrophage-specific antibody). 
Sections stained for a-SMC actin were deparaffinized, treated with 3% H2O2 for 5min to 
remove endogenous peroxidases, rinsed with dH2 0  and blocked with 0.05% Tween-20 
(Sigma Chemical Co., St. Louis, Missouri, USA) in phosphate buffered saline (PBS-T) 
for 30min. The slides were incubated for 30min with the appropriate primary antibody 
diluted in PBS-T, then rinsed with PBS-T. Sections stained for a-actin were incubated 
with Protein A-horseradish peroxidase (Sigma Chemical Co., St. Louis, Missouri, USA),
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1:500 dilution in PBS-T for 30min. Sections stained for rabbit macrophages (RAM 11) 
and T cells (CD3) were treated with the components of the LSAB-2 biotin-streptavidin 
amplification kit (DAKO, Carpinteria, California, USA) according to the supplied 
instructions with the incorporation of an avidin^iotin blocking procedure. All 
incubations were carried out in a moist chamber at room temperature. Sections were 
rinsed with PBS-T and developed by the addition of lOOp.1 of DAB substrate (Sigma Fast 
DAB, Sigma Chemical Co., St. Louis, Missouri, USA) per slide. The development was 
stopped with water and the slides counterstained with H&E or hematoxylin alone. The 
slides were dehydrated, cleared and coverslipped.
Antibody to; Clone Dilution Development Source
a-Smooth Muscle Cell Actin 1A4 1:400 Protein A-HRP Sigma
Rabbit Macrophage RAM 11 1:500 LSAB-2 Dako
T Cell/CD3 Rbt poly 1:50 LSAB-2 Dako
Macrophage Counts
Macrophages are involved in the inflammatory response toward the graft and in 
the development and progression of atherosclerosis, and the numbers present were used 
as an indirect indicator of disease severity and inflammation. Slides stained with the 
RAMI 1 antibody were used in this portion of the study. Five random lOOX fields were 
photographed at the junction between graft tissue and ablumenal tissue where the 
majority of the macrophages were loeated. The number of macrophages and giant cells 
were counted per image and averaged to obtain the count.
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Zymography
Matrix metalloproteinases (MMPs) are produced by macrophages and other cell 
types as part of an inflammatory response and could be involved in graft degeneration, 
therefore pre- and post-operative serum samples were qualitatively evaluated for 
circulating MMP levels. The conditions present during zymography allow for the 
detection of both the pro-forms and activated MMPs, due to the dissociation of the active 
MMPs from inhibitors or the spontaneous activation of zymogens
Serum samples were electrophoresed on 10% polyacrylamide gels containing 
1 mg/ml Gelatin or Elastin. The samples were diluted 1:10 (v:v) with saline and then 1:1 
with 2X Non-denaturing Sample Buffer (no (3-Mercaptoethanol), 20pl loaded onto the 
gel and run at 200 V until completion. The gels were washed 2X 30 min with 2.5% 
Triton X-lOO/dHaO with agitation, washed 30 min with RT Activation Buffer with 
agitation, and then incubated 0/N  in Activation Buffer at 37°C with agitation 
(Activation buffer 25mM Tris, lOmM CaCb, IpM ZnCli, 50mM NaCl, pH 7.5). Gels 
were stained with coomassie brilliant blue and areas of gelatinolytic or elastolytic activity 
were seen as clear bands against a blue background. The gels were then visually 
inspected for differences.
MMP activity was confirmed by incubating the gels in the presence of Immol/L 
1,10-phenantroline (MMP inhibitor) in the activation buffer in both the 30 minute wash 
and overnight incubation
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ELISA for Humoral Response
Dry graft material was lyophilized to a constant weight, suspended in 1% acetic 
acid at a concentration of Img/ml (w/v) and homogenized. The material was diluted to 
~250ug/ml with 0.02M Carbonate buffer (pH 9.6) and lOOul (~25ug/well) of collagen 
was added to each well of a 96-well plate (Falcon PRO-BIND™, Becton Dickinson and 
Company, Franklin Lakes, NJ, USA). The plates were evaporated to dryness overnight at 
room temperature in a hood. Before use, the plates were washed 4X with PBS-T and 
blocked for 45 min RT (or O/N at 4°C) with lOOul PBS-T/1% BSA per well. The wells 
were then rinsed 4X with PBS-T and serial 2-fold dilutions of serum were plated in 
PBS/1% BSA (50ul/well in duplicate). The plates were incubated at RT for Ihr and 
washed 4X with PBS-T. Anti-Rabbit IgG-HRP (Monoclonal Anti-Rabbit IgG y-chain 
specific. Clone RG-96, Peroxidase Conjugate A-1949, Sigma-Aldrich Co, St Louis, MO, 
USA) was diluted 1:40,000 in PBS-T/1% BSA and 50ul/well was added. The plate was 
incubated 2hrs at RT and washed 4X with PBS-T. OPD substrate (HRP substrate, Dako 
Corporation, Carpinteria, CA, USA) was prepared according to the manufacturers 
instructions (dissolved in room temperature dHaO and 30% H2O2 added) and 50ul of the 
substrate solution was added to each well. The color was allowed to develop BOmin at 
room temperature and the reaction stopped by the addition of 50ul of 0.5M H2SO4 to each 
well. The absorbance was read at 490nm in a microplate reader (Opsys MR, Dynex 
Technologies, Chantilly, VA, USA).
Normal rabbit serum was included as the negative control and the values obtained 
used to adjust for serum absorbance. In all cases the OD value from the normal rabbit
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serum was subtracted from the mean valued obtained for the corresponding dilutions of 
the experimental samples. The titer listed is derived from the last well giving a positive 
OD after adjustment. Blank values were obtained from wells incubated with PBS-T/1% 
BSA instead of serum and subtracted from all OD values by the microplate reader 
software.
56
Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.
Results
Post-Operative Survival and Graft Patency
Normal Diet Rabbits: Thirteen female New Zealand White rabbits were operated and a 
small-diameter bovine conduit (intemal diameter of 3-4mm) was implanted into the 
inffarenal abdominal aorta. All grafts were patent immediately after implantation as 
demonstrated by a visible and palpable pulse, and at saerifice at 2 (n=3), 4 (n=4), and 6  
months (n=3).
Hind-limb paraparesis developed in one rabbit within the first postoperative day 
and the animal died the third postoperative day. One rabbit became ischemic and was 
euthanized six days post-operatively. Post-mortem examination did not show graft 
occlusion. One animal developed bilateral dry ulcerations of the footpad. One rabbit 
died suddenly at 5 months and post-mortem examination revealed intestinal ischemia and 
graft thrombosis.
Cholesterol Diet Rabbits: Sixteen rabbits were operated and had a small-diameter 
bovine conduit (intemal diameter of 3-4mm) was implanted into the inffarenal abdominal 
aorta. All grafts were patent immediately after implantation as demonstrated by a visible 
and palpable pulse. Two rabbits died perioperatively due to complications with 
anesthesia, one was euthanized due to a spinal injury, and two were euthanized due to 
paralysis on day 2 and day 4. Five rabbits died on day 1 (n=2), day 2 (n=2), and day 3 
(n=l) of unknown causes. Five additional rabbits died of a massive hemorrhage on day 
6 , 14, 15, 20, and 46. One rabbit survived to 73 days and was sacrificed.
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Normal diet samples macroscopic
Normal Diet 2 months: Vascular grafts (Corograft™, L and D-Hydro™ treated bovine 
artery) implanted into the abdominal aorta of the three rabbits (G5824, G5827, and 
G5828) were slightly dilated on explant. One explanted graft (G5824) had an 
outpocketing near the distal suture line, the second graft (G5827) had the same and a few 
thin portions of the graft wall, and the third graft (G5828) did not have any visible thin 
spots, but the proximal suture line was constricted (Figure 1-1: 2Mo Macroscopic).
Normal Diet 4 months: One graft (G5586) appeared normal, with a diameter slightly 
larger than the abdominal aorta, the other three grafts (G5830, G5831, G5832) had large 
dilated areas, but did not appear to be aneurysmatic (Figure 1-2: 4Mo Macroscopic).
Normal Diet 6 months: The three explanted grafts (G5581, G5587, and G5588) were 
normal in appearance, with no visible areas of dilation (Figure 1-3: 6Mo Macroscopic).
Un-Implanted Graft Histology
Re-hydrated, un-implanted Corograft™ material was fixed, paraffin embedded, sectioned, 
and stained with H&E (Figure 2: Corograft™ Histology). The histology shows the 
structures present in a healthy small artery. The graft intima extends from the internal 
elastic lamina to the lumenal surface, and after processing the graft material is devoid of 
endothelial cells and only the basement membrane remains. The media is defined by the 
internal elastic lamina and the more diffuse external elastic lamina and contains 
collagenous fibers, elastic fibers and remnants of smooth muscle cells arranged in a
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Figure 1-1: Macroscopic evaluation of samples cxplantcd from 2 month normal diet 
rabbits. Excess tissue was trimmed from the graft exterior and the graft photographed. 
The graft was then opened longitudinally along the ventral aspect, pinned open and 
photographed. Any aneurysmatic changes, atherosclerotic lesions, thrombus, or areas of 
dilation were noted. Grafts are shown in both an extemal and internal view. All grafts 
were slightly dilated upon explant. Several areas of 05824 and 05827 were more dilated 
and appeared as outpocketings (*). Diagonal arrows indicate the constriction of the 
proximal suture line in 05828. t  Arrows indicate the suture lines. ->■ Arrow indicates 
the direction of blood flow.
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Figure 1-1:2 month Macroscopic
Rabbit UCi 5824 
2 m onths 12/11/01
R ahbipG  5824 
2 months 12/11/01
% «.*>“
:  m .i n il i .  12 n o i
R a b b i t* ;  5827 
2 m onthl 12/13/01
t ^ R S b i t W ^ S  i
2 months 12/M/O^
■ ■■■ W.,bbtt#<^ 5828 
'  • rm onths >2/14/01
Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.
Figure 1-2: Macroscopic evaluation of samples explanted from 4 month normal diet 
rabbits. Excess tissue was trimmed from the graft exterior and the graft pbotograpbed. 
The graft was then opened longitudinally along the ventral aspect of the graft, punned 
open and pbotograpbed. Any aneurysmatic changes, atherosclerotic lesions, thrombus, or 
areas of dilation were noted. Grafts are shown in both an extemal and intemal view. All 
grafts were dilated on explant and G5830, G5831 and G5832 bad further areas of areas of 
dilation that appeared as outpocketings (*). tArrows indicate the suture lines. ->• Arrow 
indicates the direction of blood flow.
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Figure 1-2: 4 month macroscopic
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Figure 1-3: Macroscopic evaluation of samples cxplantcd from 6 month normal diet 
rabbits. Excess tissue was trimmed from the graft exterior and the graft photographed. 
The graft was then opened longitudinally along the ventral aspect of the graft, punned 
open and photographed. Any aneurysmatic changes, atherosclerotic lesions, thrombus, or 
areas of dilation were noted. Grafts are shown in both an extemal and intemal view. 
None of the explanted grafts were dilated upon examination, t  Arrows indicate the 
suture lines. Arrow indicates the direction of blood flow.
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Figure 1-3:6 month macroscopic
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circumferential manner. The adventitia is located ablumenal to the extemal elastic 
lamina where the collagenous fibers appear more longitudinal, have a looser arrangement 
and are interspersed with elastin fibers that appear more globular in cross section. The 
nuclei seen within the graft tissue are remnants from the original cells, as this graft is not 
extracted with detergents or enzymes to remove these cellular components. All further 
descriptions of implanted graft material will be described with respect to these stmctures, 
and where possible the original graft material will be differentiated from host-derived 
cellular ingrowth and tissue deposition.
Histology of Explanted Samples from Normal diet Rabbits 
Normal Diet 2 Months (Figure 3: 2Mo Histology)
The graft matrix was well preserved in G5824 and less organized in G5727 and G5828, 
and was re-colonized by host cells in all samples. An ablumenal layer of tissue was 
present to the exterior of the grafts composed of loose collagenous tissue, blood vessels, 
adipose tissue, some giant cells and various other cells. The graft from G5824 had a 
layer of tissue of variable thickness present on the lumenal surface of the graft that 
contained some red and white blood cells (Fig. 3-lA). In G5824 and G5828, a thin layer 
of cells staining for a-smooth muscle cells actin were seen located on and just below the 
lumenal surface of the graft, and were present for about a third of the circumference (Fig. 
3-2A&C). Additional weak actin staining was seen within the graft tissue, but appeared 
to be remnants of the original actin present prior to processing, as staining was not well- 
defined, non-specific in nature, not limited to specific cells, and present in the areas 
comprising the original media. In G5827, the actin staining was confined to several small
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Figure 2; H&E of reconstituted unimplanted Corograft™ material. The three major 
layers of a small artery are clearly visible: the intima, media, and adventitia. The 
graft intima is composed of the basement membrane sitting on top of the intemal 
elastic lamina. The media is defined by the intemal and extemal elastic laminae. 
The adventitia is located ablumenal to the extemal elastic lamina. Collagen stains 
pink, Elastin does not stain and appears as translucent refractive stmctures. 
lEL, Intemal Elastic Lamina; ExEL, Extemal Elastic Lamina; CF,Collagen Fibers; 
EF,Elastic Fibers; BM, Basement Membrane.
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Figure 2; Unimplanted Corograft Histology
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blood vessels in the adventitia and the occasional actin remnant within the graft (Fig. 3- 
2B). In G5824 and G5827, macrophages and giant cells were located at the interface 
between the graft tissue and the ablumenal layer, and in G5828 formed a complete ring 
around the graft tissue and were also bound to about a third of the lumenal surface on the 
more ventral aspect of the graft (Fig. 3-1 A, B and C). Trichrome staining showed 
relatively well preserved/organized collagen within the graft in G5824 with some more 
lightly stained area which appeared to be expanded due to cellular ingrowth, while in 
G5827 and G5828 the graft collagen was expanded and interspersed with less mature 
collagen, and little of the original collagen remained (Fig. 3-3 A, B and C). Movats of 
G5824 showed that elastin was present within the graft tissue and the intemal elastic 
lamina was present. In G5827 and G5828, the intemal elastic lamina was no longer 
present, elastin fibrils were present in the medial (circumferential) layer, but the majority 
of the adventitial (longitudinal) layer and associated elastin was present in G5828 but 
missing in G5827. CD3+ cells were present within the ablumenal layer scattered 
throughout the tissue.
Normal Diet 4 Months (Figure 4: 4Mo Histology)
The graft matrix was well preserved in all samples, and appeared as two distinct layers, a 
more cellular medial layer lumenally and a less cellular adventitial layer more ablumenal. 
For samples G5586 and G5830, the graft was reeolonized with cells throughout the 
thickness with the majority of the cells present within the medial layer, while in G5831 
and G5832 the cellularity was evenly distributed throughout the graft tissue (Fig. 4-lA  to 
D). A relatively thin layer of tissue was present to the exterior of the
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Figure 3-1: 2 month normal diet samples were embedded and 5pm sections were stained 
with H&E for general tissue morphology and cellularity. All grafts were re-colonized by 
host-derived cells. All grafts had a host-derived ablumenal layer containing loose 
collagenous tissue, blood vessels, adipose tissue, some giant cells and various other cells 
(Ab). G5824 had a luminal layer containing some red and white blood cells (f). G5824, 
G5827 and G5828 had macrophages and giant cells ( |)  located at the interface between 
the graft and the ablumenal tissue. Scale bar -lOOpm.
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Figure 3-1: H&E stain of 2 month samples
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Figure 3-2:2 month normal diet samples were embedded and 5 pm sections were stained 
for a-smooth muscle cell actin, a marker of smooth muscle cells and myofibroblasts. The 
presence of aetin-staining cells would indicate the presence of host-derived 
myofibroblasts (involved in healing) or smooth muscle cells (cells normally present in 
blood vessels). G5824 and G5828 had a thin layer of cells staining for a-smooth muscle 
cell actin on and just below the lumenal surface of the graft (f). Additional weak actin 
staining was seen within the graft tissue, but appeared to be remnants of the original actin 
present prior to processing (*). In G5827, the aetin staining was confined to several 
small blood vessels in the adventitia and the oeeasional actin remnant within the graft. 
Scale bar ~100pm.
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Figure 3-2: Actin stain of 2 month samples
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Figure 3-3:2 month normal diet samples were embedded and 5 pm sections were stained 
by Massons Trichrome. This stain is for collagen integrity and organization. The darker 
blue collagen is considered more mature, while lighter staining collagen is considered 
indicative of less mature collagen. Trichrome staining showed relatively well 
preserved/organized collagen within the grafts and more lightly stained areas of 
remodeled collagen (open circles).
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Figure 3-3: Trichrome stain of 2 month samples
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graft composed of loose collagenous tissue containing blood vessels, adipose tissue, some 
giant cells and various other cells. There appeared to be a greater concentration of 
inflammatory-type cells present at the junction between the graft tissue and the ablumenal 
layer in G5586, and in G5830, G5831 and G5832 inflammatory cells were present as 
small collections (Fig. 4-lA  to D). A very thin layer of bland looking material was 
present on the lumenal surface of the graft from G5586. In G5832 a thin layer of clot 
was seen on 2 portions of lumen overlaying a layer of fibrin material containing PMNs 
(Fig. 4-lD). A thin layer of actin staining-cells was located at the lumenal surface for 
about ~3/4 of the circumference in G5586, G5830, and G5832 (Fig. 4-2A to C). Some 
actin staining cells were present within the graft tissue extending for ~l/2 of the 
circumference in G5586 and G5830. In G5832 approximately l/5th of the graft 
contained actin staining cells. In G5831, a few actin staining cells were present within 
the graft tissue, and some staining was seen ablumenally (Fig. 4-2C). Macrophages and 
giant cells were located at the interface between the graft tissue and the ablumenal layer 
and formed a complete ring aroimd the graft in G5586 (Fig. 4-lA). In G5830 
macrophages and giant cells were located at the interface between the graft tissue and the 
ablumenal layer, but fewer in number than previous samples and did not stain very 
darkly. However more giant cells were seen within the graft tissue located in the medial 
(circumferential) layer or on the lumenal surface. In G5831 scattered macrophages were 
present in the ablumenal layer and some macrophages were bound to the lumenal surface 
of the graft, few giant cells were present and were located at the edge of the graft. In 
G5832 macrophages and a few giant cells were located at the interface between the graft 
tissue and ablumenal layer and macrophages were seen within the surface fibrin layer.
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Trichrome staining of G5586 and G5830 showed the majority of the collagen present was 
lightly stained and appeared to be expanded due to cellular ingrowth (Fig. 4-3A&B). In 
G5831, Trichrome staining showed the majority of the collagen present was well 
preserved and mature fibrils were present more ablumenally. The remainder was lightly 
stained and appeared to be expanded due to cellular ingrowth (Fig. 4-3C). In G5832, 
Trichrome staining showed a band of more mature collagen at the lumenal surface while 
the more ablumenal layer was composed primarily of lightly stained collagenous material 
(Fig. 4-3D). Movats staining of G5586 showed that thicker elastin fibrils were present 
within the medial (circumferential) graft tissue and elastin was abundant within the 
longitudinal tissue. Several portions of the intemal elastic lamina were still visible. 
Movats staining of 5830 and 5831 (5832 H&E) showed that little elastin was present and 
what remained appeared to be remnants of the original graft elastin. No intemal elastic 
lamina visible was visible in these samples. All samples had CD3 + cell present within 
the ablumenal layer scattered throughout the tissue.
Normal Diet 6 Months (Figure 5: 6Mo Histology)
The graft matrix of all samples was relatively well preserved, appearing as two distinct 
layers medial (circumferential) and adventitial (longitudinal) for most of the implant, 
with cellularity that was evenly distributed between the layers. Graft G5587 had two 
large collections of fibrinous tissue adherent to the lumenal surface that occupied about 
1/3 of the surface and protmded into the lumen of graft. A relatively thin ablumenal 
layer was present to the exterior of the graft composed of loose collagenous tissue 
containing blood vessels, adipose tissue, few to no giant cells and various other cells.
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Figure 4-1:4 month normal diet samples were embedded and 5 pm sections were stained 
with H&E for general tissue morphology and cellularity. All grafts were re-colonized by 
host-derived cells and had an ablumenal layer of tissue containing blood vessels and 
adipose tissue. Inflammatory cells were seen within the ablumenal tissue and 
representative areas are enclosed within the circles. G5832 had a thin layer of luminal 
clot containing PMNs (f). Macrophages and giant cells were located at the interface 
between the graft tissue and the ablumenal tissue in all grafts (f). Scale bar ~100pm
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Figure 4-1: FI&E of 4 month normal diet
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Figure 4-2: 4 month normal diet samples were embedded and 5 pm sections were stained 
for a-smooth muscle cell actin, a marker of smooth muscle cells and myofibroblasts. The 
presence of actin-staining cells would indicate the presence of host-derived 
myofibroblasts (involved in healing) or smooth muscle cells (cells normally present in 
blood vessels). A thin layer of actin staining-cells was located at the lumenal surface in 
G5586, G5830, and G5832 ( |)  and varying amount of actin staining cells were seen 
within the graft tissue of all sample
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Figure 4-2: Actin stain of 4 month normal diet
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Figure 4-3: Trichrome stain of 4 month normal diet samples. Five pm sections were 
stained by the Trichrome method of Masson. This stain is for collagen integrity and 
organization. The darker blue collagen is considered more mature, while lighter staining 
collagen is considered indicative of less mature collagen. Trichrome staining of G5586 
and G5830 showed the collagen appeared to be expanded due to cellular ingrowth (open 
circle). In G5831, Trichrome staining showed the majority of the collagen present was 
well preserved and the remainder was appeared expanded due to cellular ingrowth (open 
circle). In G5832, Trichrome staining showed a band of more mature collagen at the 
lumenal surface while the more ablumenal layer was composed primarily of lightly 
stained collagenous material (open circle). Scale bar -lOOpm.
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Figure 4-3: Trichrome stain of 4 month normal diet
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There were few inflammatory-type cells present at the junction between the graft tissue 
and the ablumenal layer (Fig. 5-lA  to C). No apparent actin staining was seen within the 
grafts from G5581 and G5588, while an occasional cell was stained for actin in G5587 
(Fig. 5-1A to C). Few blood vessels were present and stained for actin in the ablumenal 
layer. Scattered macrophages were present in the ablumenal layer but few giant cells 
were present. A few macrophages were bound to the lumenal surface of the grafts, and 
were also present near the surface of the fibrinous tissue in G5587. Trichrome staining of 
G5581 showed the majority of the collagen present was well preserved and mature fibrils 
were present in the ablumenal layer (Fig. 5-3A). The remainder was lightly stained and 
appears to be expanded due to cellular ingrowth. Trichrome staining of G5587 showed 
the majority of the collagen present was lightly stained and appears to be expanded due to 
cellular ingrowth (Fig. 5-3B). Trichrome staining of G5588 showed a minority of the 
collagen present was as mature fibrils that appeared to be remnants of the original graft 
(Fig. 5-3C). The remainder was lightly stained and appeared to be expanded due to 
cellular ingrowth. Movats of G5581 and G5587 showed that a few elastin fibrils were 
present, but appeared to be remnants o f original graft elastin in the adventitial 
(longitudinal) layer. Fragments of the internal elastic lamina were visible in G5581 and 
5587, but absent in G5588. CD3 + cells were present scattered throughout the ablumenal 
layer.
Cholesterol-diet samples macroscopic
Cholesterol Diet 2 months: The graft from the single cholesterol diet rabbit (G6185) 
appeared dilated, with a large outpocketing just below the proximal suture line where
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Figure 5-1: H&E stain of 6 month normal diet samples. Five pm sections were stained 
with H&E for general tissue morphology and cellularity. The graft matrix of all samples 
was well preserved and appeared as two distinct layers that were re-colonized by host- 
derived cells. All grafts had a relatively thin ablumenal layer exterior to the graft 
material composed of loose collagenous tissue containing blood vessels, adipose tissue, 
scattered macrophages and a few inflammatory-type cells (circles).
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Figure 5-1: H&E stain of 6 month normal diet
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Figure 5-2: Actin stain of 6 month normal diet samples. Five pm sections were stained 
for a-smooth muscle cell actin, a marker of smooth muscle cells and myofibroblasts. The 
presence of actin-staining cells would indicate the presence of host-derived 
myofibroblasts (involved in healing) or smooth muscle cells (cells normally present in 
blood vessels). No apparent actin staining within the grafts from G5581 and G5588, 
while an occasional cells was stained for actin in G5587 (*).
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Figure 5-2: Actin stain of 6 month normal diet
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Figure 5-3: Trichrome stain of 6 month normal diet samples. Five pm sections were 
stained by the Trichrome method of Masson. This stain is for collagen integrity and 
organization. The darker blue collagen is considered more mature, while lighter staining 
collagen is considered indicative of less mature collagen. Trichrome staining of G5581 
and G5587 shows a portion of the collagen was well preserved and the remainder appears 
expanded due to cellular ingrowth (open circle). Trichrome staining of G5588 showed a 
minority of the collagen present was as mature fibrils that appeared to be remnants of the 
original graft (*). The remainder was lightly stained and appeared to be expanded due to 
cellular ingrowth (open circle).
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Figure 5-3: Trichrome stain of 6 month normal diet
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wall of the graft was thinner than the remainder (Figure 6A and B): Cholesterol diet 
Macroscopic).
Cholesterol diet Macroscopic Aneurysm samples (Figure 6C to F)
Five cholesterol-diet rabbits died postoperatively on days 6,14,15, 20, and 46. Post­
mortem examination revealed the presence of a massive hemorrhage either into the 
abdominal cavity or retroperitoneally due to an apparent graft rupture.
Cholesterol-diet Histology 
2 Months (Figure 7-1: 2Mo Histology)
Graft matrix was unorganized, and less cellular than the normal counterparts. The 
ablumenal layer contained very loose collagenous tissue, blood vessels, some adipose 
tissue, as well as many giant cells and a several large patches of inflammatory cells. The 
medial layer appeared expanded, while the adventitial layer was a thick layer of very 
loose tissue containing many cells with large cytoplasmic areas containing translucent 
granular material that appear to be foam cells (Fig. 7-lA). A thin layer of actin staining- 
cells were located at or on the lumenal surface staining for about a third of the 
circumference (Fig. 7-lB). Actin staining was also seen in two small blood vessels in the 
adventitia and the occasional actin remnant within the graft. Giant cells, macrophages 
and foam cells were located within the expanded adventitial tissue. Macrophages also 
formed an almost complete layer at the lumenal surface of the graft (Fig. 7-lA). 
Trichrome indicated that the majority of the graft collagen was degraded and what 
remained was mainly less mature collagen with a filamentous appearance (Fig. 7-lC).
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Figure 6: Macroscopic evaluation of cholesterol diet samples. Panels A&B are 
photographs of the graft harvested from the cholesterol diet rabbit at 2 months and shows 
the outpocketing of the graft near the proximal suture line (*). Panels C to F are 
aneurysm samples at 6 ,14,15,20 and 46 days respectively. The area of rupture for these 
samples is indicted by the |  arrows, tArrows indicate the suture lines and the flow of 
blood is fi'om left to right.
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Figure 6: Cholesterol Diet and Aneurysm Samples Macroscopic 
A J b
Rabbit ?/<; 61S5 
2 months l2 '2 rtH I t i i h h i t  # ( ;  6 I S 5  2 nioiith.i 12/21/01
C
7
tluii
6 d ay
j 11/05/01
14 d ay
iuA ial at , « «
15 day
4 6  day
t C i61 8
20  d ay
( IK'CCSK̂  ̂t!
Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.
The majority of the internal elastic lamina was present with fine filamentous elastin 
fibrils present in the expanded medial (circumferential) layer with no apparent 
organization. Single scattered CD3+ cells and several small groupings were present in 
the ablumenal layer.
Rabbits (Figure 7-2: Cholesterol Diet Aneurysm Histology)
Extensive collagen and elastin firagmentation was seen in all samples (Figure 7-2A, C, E 
and I). In all cases, the normal vessel architecture was disrupted due to the infiltration of 
the graft matrix by numerous macrophage/foam cells (Figure 7-2B, D, F and J). No 
evidence of actin staining was seen in any of the samples except in the occasional 
ablumenal blood vessel. The internal elastic lamina was still intact in the 6 and 14 day 
samples, but was fragmented in the 15, 20, and 46 day samples. The adventitial elastin 
was degraded in 14, 15, 20 and 46 day samples. In one case (15 day sample) 
extravascular blood was seen within the graft matrix. The graft matrix in these samples 
resembled atheroma that developed in the thoracic artery (Figure 7-3: Atheroma).
Macrophage Counts
Slides stained with RAMI 1, a rabbit-macrophage-specific antibody, were used in 
this portion of the study. Photographs of 5 high-power fields were taken at the junction 
of the graft adventitial tissue and the ablumenal layer where macrophages/giant cells 
were common. If possible, the field contained a portion of the graft adventitial tissue. 
The macrophage counts from the five random lOOX fields were averaged for each 
sample, and the mean number of macrophages per group generated from these values.
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Figure 7-1: Histology of 2 month cholesterol diet sample. Panel A is the H&E stain of 
the graft. The graft matrix was less cellular than the normal coimterparts at 2 months and 
the graft material was expanded. Giant cells, macrophages and foam cells were located 
within the expanded adventitial tissue (M). Macrophages also formed an almost 
complete layer at the lumenal surface o f the graft (*). Panel B is the actin stain of the 
graft and shows a thin layer of actin staining-cells located at or on the lumenal surface 
(f). Panel C is the Trichrome showing that the majority of the graft collagen was 
degraded and had a filamentous appearance (open circle). Scale Bar -lOOpm
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Figure 7-1: H&E, Actin and Trichrome of 2 month Cholesterol Diet Graft
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Figure 7-2: Cholesterol Diet Aneurysm Histology. Panels A, C, E, G and I are H&E 
stains of the samples. In all samples the collagenous graft material has been degraded and 
a cellular influx is seen in all samples. These cells are presumably macrophage derived 
foam cell based on the cellular morphology and foamy-looking cytoplasm. Panel B, D, F 
and J are RAMI 1 macrophage stains, confirming the identity of these cells as 
macrophages (open circles).
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Figure 7-2: Aneurysm Flistology
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Figure 7-3: Histology of the thoracic aorta from normal and atherosclerotic rabbits. 
In panel A the histology of a normal rabbit thoracic artery is visible showing the 
Intima (*Endothelial cells), Media and Adventitia. Panels B and C show a well 
developed Atheroma in a rabbit thoracic aorta stained with H&E for morphology 
and RAMI 1 for macrophages, respectively. The layers of the artery are visible, 
though little evidence of the aortic intima remains. The atheroma has developed 
above the internal elastic lamina (lEL) and protrudes into the lumen. The 
atheroma is dominated by foam cells and extraeellular matrix, giving it a loose, 
disorganized appearance. The inset shows the foam cells (granular, vacuolated 
cytoplasm) and extracellular matrix in more detail. Scale bar -lOOpm
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Figure 7-3: Normal and Atherosclerotic Aorta
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No statistically significant differences were seen between 2 ,4  and 6 month 
samples from rabbits fed a normal diet. Cholesterol diet samples from aneurysm samples 
showed numerous macrophages but could not be counted due to overlap. The 
macrophage count from the cholesterol diet rabbit sacrificed at 2 months was similar to 
the normal diet samples and was not significantly different.
Zymography
No major observable differences in band intensity were seen between surgery and 
sacrifice samples (Figure 8: Zymograms). The MMP profile did not change between 
groups, or between normal diet and cholesterol diet. Development in the presence of 
1,10-phenanthroline MMP inhibitor indicated that the majority of the gelatinolytic 
activity was due to MMPs, with very little due to proteases (data not shown).
Humoral ELISA (Host Humoral Immune Response toward Graft)
In all cases the humoral response to the graft increased between surgery and sacrifice 
(Table 4: ELISA Titers). The overall trend over the 6 month period was a reduction in 
the humoral response toward the graft material (Figure 9: Log ELISA). No statistical 
significance could be determined between groups as the number of samples in each group 
were too few.
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Table 3; Macrophage counts were done on slides stained for RAMI 1 from normal and 
cholesterol diet samples. Five high-power fields were photographed at the junction of the 
graft material and the ablumenal host tissue where the majority of the macrophages were 
located. The macrophages were manually counted, and the number averaged to obtain 
the given values. No significant differences were seen between groups. Values are Mean 
±SEM
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Table 3: Macrophage Counts - Diet
Rabbit # Diet A v g # o f
Macrophages
Mean # of 
Macrophages^
G5824 2 month Normal 42.6
26.8+7.9G5827 2 month Normal 19.2
G5828 2 month Normal 18.6
G5586 4 month Normal 41.2
27.05+5.1G5830 4 month Normal 22
G5831 4 month Normal 27.4
G5832 4 month Normal 17.6
G5581 6 month Normal 41.6
37.8±8.1G5587 6 month Normal 33.6
G5588 6 month Normal 38.4
G6185 2 month Cholesterol 34.8 34.8
G6409 6 dayt Cholesterol TNTC ND
G6405 14 dayt Cholesterol TNTC ND
G6186 15 dayt Cholesterol TNTC ND
G6183 20 dayt Cholesterol TNTC ND
G6182 46 dayt Cholesterol TNTC ND
Average of 5 high-power fields
Mean ± SEM
TNTC -  Too numerous to count
ND -  Not done
tAneurysm Samples
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Figure 8: To analyze differences in MMP presence or expression between surgery and 
sacrifice samples, equivalent amounts of serum were electrophoresed on 10% acrylamide 
gels containing 1% gelatin. The gels were run to completion, washed to remove SDS, 
and incubated in activation buffer (with and without MMP inhibitor) for the appropriate 
time. Gels were stained with coomassie brilliant blue, and active bands appear as clear 
bands on a blue background. No observable differences were seen within or between 
groups, or between diet types for all rabbits. *Cholesterol diet
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Figure 8: Zymograms of 2, 4 and 6 month Samples - Diet
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Table 4: Serum samples were collected and stored at -60°C until all had been collected 
then the humoral response toward the graft material was quantified by the humoral 
ELISA. Each sample was analyzed in duplicate, with each plate containing an internal 
blank. All readings were averaged, adjusted for normal rabbit serum OD, and the 
reciprocal given.
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Table 4: ELISA titers of 2 ,4  and 6 Month Samples - Diet
Rabbit # Titer @ 
Surgery
Titer @ 
Sacrifice
G5824 Normal Diet 2Mo 20 20480
G5827 Normal Diet 2Mo 20 10240
G5828 Normal Diet 2Mo 40 20480
G5586 Normal Diet 4Mo 20 640
G5830 Normal Diet 4Mo 20 1280
G5832 Normal Diet 4Mo 20 1280
G5831 Normal Diet 4Mo 20 20480
G5588 Normal Diet 6Mo 20 320
G5581 Normal Diet 6Mo 20 640
G5587 Normal Diet 6Mo 20 1280
G6185 Cholesterol Diet 2Mo 20 20480
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Figure 9: The log of the ELISA titers were plotted to graphically show the differences 
between the humoral response to the graft material at surgery and then at sacrifice. In all 
cases there was an increased humoral response to the graft between surgery and sacrifice. 
Over the 6 month period the overall trend shows a decreased humoral response toward 
the graft material. No statistical significance could be determined as there were too few 
samples in each group. Normal diet 2 month samples: G5824, G5827 and G5828. 
Normal diet 4 month samples: G5586, G5830, G5831 and G5832. Normal diet 6 month 
samples: G5581, G5587 and G5588. Cholesterol diet 2 month sample: G6185.
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Figure 9: Humoral ELISA of 2 ,4  and 6 Month Samples - Diet
Humoral ELISA - Diet
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Table 5: The histology, immunohistology, macrophage counts, and ELISA information 
were summarized to provide an overview of the results for the 2, 4 and 6 Month Samples.
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Table 5: Complied results for 2 ,4  and 6 month samples - Diet
Animal # Graft
Cellularitv
Actin Collagen
Remodel
Macrophage
Presence
Tissue
Destruction
Humoral
response
G5824 2mo + ++ + + - ++++
G5827 2mo +++ + ++ + - ++++
G5828 2mo +++ + ++ ++++ - ++++
G6185 2mo* -/+ + ++++ ++ ++++ ++++
G5586 4mo ++ ++++ +++ + - +++
G5830 4mo + ++++ +++ + - +++
G5831 4mo + + + + - +++
G5832 4mo + ++ + - - ++++
G5581 6mo ++ + +++ + - ++
G5587 6mo ++ + +++ + - +++
G5588 6mo + - +++ -/+ - ++
* Cholesterol Diet
Graft Cellularity -(0%) —» ++++ (100%) re-colonization of graft material hy host cells. 
Actin -(0%) —> ++++ (100%) recolonization of graft media hy actin-positive cells. 
Collagen Remodel -(0%) ++++ (90-100%) newly produced collagen vs. mature.
Macrophage Presence -(few macrophages) —̂ ++++ (40-50) avg. # macrophages. 
Tissue Destruction -(0%) —> ++++ (100%) destruction of original graft material. 
Humoral Response -(0%) ++++ (100%) of maximum response, rated relative to the
highest response seen for all grafts.
I l l
Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.
Discussion
Effects of Atherosclerosis
With the need for alternative bypass conduits increasing each year, the effects of 
hypercholesterolemia on non-autologous grafts needs to be studied, and grafts need to be 
tested in a less-than-favorable environment to more accurately determine durability and 
outcome. Many studies have implanted autologous, heterologous, xenogenic or synthetic 
vascular grafts into the circulation of normal animals, while other studies have evaluated 
the effect of an atherogenic diet on the development atherosclerosis. Few studies have 
directly evaluated the effect of atherosclerosis on vascular grafts, and then the effect of
16 52 53 59 78experimental atherosclerosis on autologous vein grafts ’ ’ or synthetic grafts ’ in 
rabbits was examined.
Review of published literature shows little has been published on the effect of 
experimental hypercholesterolemia on xenograft durability. This chapter addresses this 
issue directly, and was designed to assess the role of inflammation on the graft material 
by increasing inflammation via diet-induced atherosclerosis. Two groups of rabbits were 
fed a normal diet or an atherogenic diet supplemented with cholesterol, allowing for the 
evaluation of the long-term outcome of this graft in a disease model, which had not 
previously been done. Weekly bleeds were done on both the normal and cholesterol diet 
rabbits to monitor serum cholesterol levels and inclusion of cholesterol into the diet 
resulted in a considerable elevation in pre-operative serum cholesterol compared to 
rabbits fed a normal diet.
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Normal diet rabbits
Rabbits fed the normal diet recovered well from surgery and on explant at 2 ,4  
and 6 months the grafts were found to be incorporated into the host. The grafts were 
covered with host-derived tissue with little evidence fibrosis. Further microscopic 
analysis of the samples showed the graft material was re-colonized by host-derived cells. 
However, macrophages were a common finding in the tissue surrounding the grafts and 
giant cells and scattered T-cells were also present. This indicated that the graft material 
did appear to elicit a chronic inflammatory type response, but the response was not severe 
enough to result in graft failure. This could be considered an advantage as the 
inflammatory response appears to promote the formation of new vessels that may support 
the graft tissue. The healing of the grafts appeared to be ongoing out to 6 months and 
longer studies would be interesting as they would show whether the graft becomes fully 
incorporated into the host and develops a functional intima and media. Functional studies 
could also be done to show whether the vessels becomes responsive to stimuli normally 
present in the vasculature (vasodilatation and vasoconstriction).
Cholesterol diet rabbits
By comparison the majority of cholesterol-diet rabbits did not survive longer than 
a few days post-operatively. The reasons for this are unclear, but may be a due to the 
combined stress of the surgery in conjunction with the systemic stress of atherosclerosis 
resulting in the death of the animals. This could be explored by the addition of sham 
surgeries as an experimental group, in which the entire surgical procedure including 
cross-clamping the aorta for 30 minutes without implanting the graft, would be
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performed. This would allow us to evaluate the effect of the surgery on post-operative 
survival in hypercholesterolemic rabbits, and see whether the surgery is contributing to 
the increased mortality.
The effects of hypercholesterolemia on the graft
Five of the rabbits that survived the immediate post-operative period died of a 
burst aneurysm of the graft material between 6 and 46 days. Microscopic examination of 
these post-mortem aneurysm samples, as well as graft material from the single surviving 
cholesterol-diet rabbit at 2 months, showed the presence of numerous foam cells, little 
collagen and elastin, and extensive destruction of tissue architecture. The appearance of 
the expanded graft tissue as well as atheromatous plaque tissue harvested from the 
thoracic aorta was very similar, and both contained numerous macrophage-derived foam 
cells. The ubiquitous presence of foam cells and the lack of other cell types in the area of 
the aneurysm, in conjunction with the graft tissue destruction in these areas, appears to 
implicate these cells in the development and progression of the aneurysm leading to 
rupture.
The histology data suggest that hypercholesterolemia is associated with an 
increased presence of foam cells and degradation of the graft material. This could lead to 
graft degeneration as well as aneurysm formation and rupture, which could be due to the 
increased production and activity of lytic enzymes by the macrophages in atherosclerotic 
rabbits. Previously published studies have shown that hypercholesterolemia increases the
C l  'y Q
presence of macrophages within the aortic tissue of rabbits ’ ’ and withdrawal of 
dietary cholesterol reduces the presence of macrophages within atherosclerotic lesions
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Atherosclerosis has been associated with the development of aneurysms due to an 
increase in the inflammatory response and the production of lytic enzymes that degrade 
extracellular matrix components that are secreted by macrophages .
The zymography data did not show an increase in circulating serum MMPs, but 
the serum levels may not accurately reflect the levels of MMPs within the graft material. 
Even though the presence of MMPs in serum is supposedly proportional to the amount in 
tissue (at least in published studies of aneurysm formation), the serum samples collected 
in this study may not truly reflect the MMP amount and activity within the graft tissue. 
Additionally, the degeneration within the grafts is localized to a small portion of the 
vasculature and the differences may not be detectable with the methodology employed. 
Also, the MMP activity seen reflects the total amount of MMP present within the serum 
and does not differentiate between what was originally active or inactive Western 
blotting of graft extracts or immunohistology of graft sections for the presence and 
relative amounts specific lytic enzymes known to degrade matrix components (such as 
MMP2 and 9) could be used to explore the differences between the normal and 
atherosclerotic grafts.
Graft durability in an atherosclerotic rabbit model
The grafts harvested from the one surviving rabbit fed an atherogenic diet and the 
samples obtained from the cholesterol-diet rabbits that died from ruptured grafts provide 
an interesting glimpse into the effect of atherosclerosis on graft durability and these 
observations may directly apply to the failure of grafts in human patients and merits 
flirther investigation. One of the original goals for the study was to study the effect
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atherosclerosis on the long-term durability o f graft material, but due to the elevated 
mortality this was difficult to assess using this model. However, atherosclerosis appears 
to have a negative effect on long-term durability due to the increased inflammatory 
response. However major modifications of this model would be required before further 
studies could be done to address the role of atherosclerosis on graft durability.
Several studies could be done to further explore this phenomenon. Initially a 
study would be done to eorrelate the level of cholesterol to the level of inflammation seen 
in the rabbit, so a particular stage in the formation of atherosclerosis (early, intermediate 
or late stage) could be targeted and then the graft could be implanted. A study could be 
done in which the graft would be implanted into the abdominal aorta and upon recovery 
the hypercholesterolemic diet would be started. This should demonstrate the effect of 
atherosclerosis on the graft for an extended period of time. Another study would involve 
inducing hypercholesterolemia in the rabbit but adjusting the diet to keep the serum 
cholesterol in the clinically significant range for humans and then implanting the graft. 
This would be a more relevant model to explore the effect of atherosclerosis on the graft 
under similar conditions to humans.
Conclusions
Rabbits fed a normal diet survive the surgery well and the grafts remain patent for 
up to 6 months. The explanted grafts are recolonized by host cells and the arrangement 
of these cells corresponds with the normal distribution of cells within a normal artery. 
However, in this rabbit model the grafts elicit a chronic-type inflammatory response
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which would allow this model to be used for further study in which the inflammatory 
response could be addressed by the incorporation of anti-inflammatory drugs.
Rabbits fed a cholesterol-supplemented diet had a very high incidence of post­
operative mortality attributed to systemic and operative stress. Aneurysm formation was 
seen in several rabbits. Hypercholesterolemia increases the presence of macrophages 
within the grafts which are known to produce MMPs that degrade matrix components, 
while fragments of matrix could serve as an additional stimulus, leading to an increased 
response toward the graft tissue. Based upon the histological data there seemed to be an 
accelerated development of atherosclerotic lesions with the graft tissue, leading to rupture 
and death in a select subset of these animals. While this model is flawed as a way to 
assess the effect o f atherosclerosis on the graft material over an extended period of time, 
the methodology could be re-designed to allow for longer term observations.
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Appendix
Table 6: Surgery and sacrifice data for all the rabbits in this study are complied in this 
table. The weights at surgery and sacrifice are listed, and the cholesterol diet rabbits had 
a lower operative weight compared to the normal diet rabbits, which was increased at 
sacrifice . The average graft length for the normal diet group was 4.4cm and 4.5cm for 
the cholesterol diet groups. The cross-clamp times did not differ significantly between the 
groups (22min normal vs. 19min cholesterol).
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Table 6: Surgery and Graft Data - Diet
Rabbit
#
Surgery
Date
Weight @ 
Surgery
Graft
Length
X-Clamp
(min)
Graft# Date
Opened
Sacrifice
Date
Weight @ 
Sacrifice
Normal Diet
G5588 09/17/01 4.4kg 4.5cm 20 AP25.225 09/17/01 03/22/02 5.68kg
G5583 09/18/01 4.3 4.3 21 AP25.225 09/17/01 09/21/01 N/A
G5581 09/19/01 4.5 4.6 21 AP25.225 09/17/01 03/26/02 5.56
G5584 09/20/01 4 4.5 23 AP25.225 09/17/01 03/09/02 N/A
G5587 09/20/01 4.3 4.5 17 AP25.225 09/17/01 03/26/02 4.88
G5586 09/21/01 3.8 3.6 22 AR25.21 09/21/01 01/25/02 4.66
G5830 09/25/01 4.8 4.5 22 AR25.21 09/21/01 02/01/02 5.7
G5832 09/25/01 4.3 4.5 20 AR25.21 09/21/01 01/28/02 5.1
G5831 09/27/01 4.7 4.7 24 AR25.21 09/21/01 02/04/02 4.09
G5828 09/27/01 4 4.7 20 AR25.21 09/21/01 12/14/01 4.65
G5825 09/28/01 4.2 4.4 29 AR25.211 09/28/01 10/04/01 N/A
G5824 09/28/01 4.7 4.3 18 AR25.211 09/28/01 12/11/01 4.7
G5827 10/03/01 4.3 4.6 19 AR25.211 09/28/01 12/13/01 5.4
G5826 N/A 3.8 N/A N/A N/A N/A N/A N/A
Mean ± Std Dev 4.29±0.3 4.44±0.3 22±3 5.04±0.5
Cholesterol Diet
G6186 10/08/01 4 4.1 22 AR25.211 09/28/01 10/23/01* N/A
G6185 10/09/01 2.7 4.5 15 AR25.211 09/28/01 12/21/01 2.95kg
G6182 10/10/01 3.8 4.7 21 AR25.211 09/28/01 12/10/01* N/A
G6183 10/11/01 3.3 4.5 20 AR25.222 10/11/01 10/31/01* N/A
G6184 10/11/01 3.4 4.5 21 AR25.222 10/11/01 10/14/01* N/A
G6188 10/12/01 3 4.8 15 AR25.222 10/11/01 N/A N/A
G6404 10/15/01 3.1 4.5 18 7AR25.222 10/11/01 N/A N/A
G6407 10/15/01 3.1 4.5 18 2AR25.222 10/11/01 N/A N/A
G6403 10/18/01 3 4.6 21 AR25.216 10/18/01 N/A N/A
G6405 10/18/01 3 4.1 12 AR25.216 10/18/01 11/01/01* N/A
G6402 10/19/01 2.9 4.5 14 7AR25.216 10/18/01 10/23/01* N/A
G6406 10/19/01 2.9 4.3 24 2AR25.216 10/18/01 10/21/01* N/A
G6408 10/30/01 3 4.6 27 7AR25.216 10/18/01 N/A N/A
G6409 10/30/01 3.2 4 20 7AR25.216 10/18/01 11/05/01* N/A
G6187 11/01/01 3.5 4.9 17 AP25.215 11/01/01 11/03/01* N/A
G6189 11/01/01 3.3 4.7 21 AP25.215 11/01/01 11/03/01* N/A
Mean ± Std Dev 3.15±0.3 4.51±0.3 18.9±3.9 2.95
*Found dead on the listed date
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Table 7: The sacrifice dates are listed for all rabbits, as is the duration of the graft 
implantation. The causes of death are listed and rabbits were sacrificed on time, 
euthanized due to complications or found dead.
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Table 7: Sacrifice - Diet
Rabbit # Cause of Death Duration
Normal Diet Rabbits
G5588 Sacrificed 6 months/186 days
G5581 Sacrificed 6 months/188 days
G5587 Sacrificed 6 months/187 days
G5586 Sacrificed 4 months/126 days
G5830 Sacrificed 4 months/129 days
G5832 Sacrificed 4 months/125 days
G5831 Sacrificed 4 months/130 days
G5828 Sacrificed 2 months/78 days
G5824 Sacrificed 2 months/74 days
G5827 Sacrificed 2 months/71 days
G5583 Paralysis - Euthanized 3 days
G5825 Ischemia - Euthanized 6 days
G5584 Died - Intestinal Ischemia 5+ months/170 days
G5826 Spinal Injury - Euthanized N/A
Gholestero Diet Rabbits
G6185 Sacrificed 73 days
G6182" Hemorrhage 46 days
G6183’ Hemorrhage 20 days
G6186" Hemorrhage 15 days
G6405" Hemorrhage 14 days
G6409* Hemorrhage 6 days
G6184 Surgical Hemorrhage 3 days
G6408 Surgical Complications 1 day
G6404 Spinal Injury - Euthanized N/A
G6403 Peri-operative - Anesthesia N/A
G6188 Peri-operative - Anesthesia N/A
G6402 Paralysis - Euthanized 4 days
G6406 Paralysis - Euthanized 2 days
G6189 Paralysis - Euthanized 2 days
G6187 Died 2 days
G6407 Died 1 day
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Chapter 3
The effect of a decreased inflammatory response on graft survival 
Introduction 
Inflammation
Inflammation has been linked to the development intimal hyperplasia 
atherosclerosis and aneurysm ’ and in all cases there is a response involving resident 
and inflammatory cells, matrix metalloproteases (MMPs) and the extracellular matrix. 
During an inflammatory type response there is an influx of cells into the area and 
macrophages are a major component of this influx later in the response. This is 
significant because macrophages have been implicated in the degradation of collagen 
under normal and pathological. They are present during the development and progression 
of atherosclerosis and in aneurysm formation where their activity is due to
increased MMP production or activity In vitro, binding to collagen increased the 
differentiation of monocytes to macrophages and increased the release of MMP9 
Based on these observations, macrophages appear to be directly involved in the 
degeneration of the graft material and eventual failure leading to the hypothesis that 
inflammation plays a key role in vascular graft failure.
It was hypothesized that any inflammatory response seen toward the graft 
material in the previous chapter would be reduced by the administration of anti­
inflammatory or anti-macrophage drugs to the rabbits. Two drugs were selected: 
Indomethacin, a non-specific anti-inflammatory agent and Etidronate, a specific anti-
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macrophage agent to test this hypothesis and compared the results to a control group 
treated with saline. Treatment with these drugs would allow for the determination of 
whether a reduction in the overall inflammatory response (Indomethacin) would increase 
graft durability or if  macrophages specifically could be targeted to increase durability 
(Etidronate).
Indomethacin
Indomethacin belongs to the family of non-steroidal anti-inflammatory drugs 
(NSAIDs) that include aspirin and ibuprofen, and exert their action by specifically 
inhibiting the activity of cyclooxygenase (COX). In contrast to the action of aspirin, 
which irreversibly inactivates COX I and 2 via an acetylation reaction, Indomethacin 
causes a slow and reversible enzyme inhibition by the formation of a salt bridge between 
the carboxylate of indomethacin and the arginine at position 120 of COX 1 and 2, located 
in the hydrophobic tunnel constituting the active site of the enzyme COX 3 is 
inhibited by acetaminophen but no mechanism is suggested.
The cyclooxygenases (COX I and 2, alternately spliced isozymes) are involved in 
the production of prostaglandins from arachidonic acid. COX I is mostly present in 
platelets, is constitutively expressed, and is involved in the production of platelets, 
prostaglandin Ei for kidney function, and prostaglandin I2 for mucus production in the 
stomach, while COX 2 is the isoform that is induced in cells by an inflammatory 
stimulus, and is involved in the production of prostaglandin E2 (PGE2) which produces 
the redness, swelling and vasodilatation in the inflammatory process COX 3, a
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variant of COX 1, is present in brain tissue and appears to be involved in the fever
response.
Indomethacin has been used experimentally to reduce the severity of 
atherosclerosis in rabhits and to prevent elastase-induced aneurysm formation in the 
rat In both atherosclerosis and aneurysm formation, macrophages are known to 
elaborate matrix metalloproteinases (MMPs), which are involved in the degradation of 
extracellular matrix components of the tissue and it is this action that is involved in the 
pathology and progression of these diseases. Indomethacin exerts an effect via inhibition 
of COX 2, down-regulating PGE2 expression and in doing so, down-regulating the 
production of MMP9 and attenuating aneurysm formation in an elastase-perfused 
abdominal aortic rat model Administration of indomethacin also suppressed the 
formation of intimal hyperplasia in a balloon injury rat model in a COX 1-dependent 
manner Administration of indomethacin should therefore inhibit both aneurysm 
formation and anastomotic hyperplasia..
Etidronate
Bisphosphonates are very stable non-hydrolyzable analogs of pyrophosphate 
characterized hy two chemically and enzymatically stable C-P bonds This class of 
drugs are used therapeutically in diseases of the hone (e.g. Osteoporosis, Paget’s disease. 
Ectopic calcification. Hypercalcemia), specifically inhibiting bone resorption and 
mineralization by inhibiting the growth/hreakdown of hydroxyapatite crystals by 
binding tightly to calcium.
135
Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.
Bisphosphonates can be subdivided into non-amino and amino containing 
compounds which function by different mechanisms. The mode of action of non-amino 
containing bisphosphonates (e.g. Clodronate and Etidronate) appears to be primarily due 
to a ‘suicide’ mechanism, whereby the drugs are metabolized by macrophage-like cells 
by incorporation into ATP This produces a non-hydrolyzable ATP analog and 
accumulation leads to cell death (osteoclasts and macrophages) The remainder of 
the (amino-) bisphosphonates (e.g. Pamidronate and Alendronate) inhibit isopentyl 
diphosphate synthase or famesyl diphosphosphate synthase in the mevalonate pathway 
which ultimately affects the prenylation of small GTP-binding proteins inhibiting 
the formation of cholesterol, and ultimately activate caspases leading to apoptosis 
The effect of bisphosphonates on macrophage function and survival is well 
documented in the literature ’ ’ . These drugs are shown to accumulate in the
tissues of both normal and atherosclerotic rabbits reduce plaque formation and severity 
as well as calcification An unexpected collateral effect of bisphosphonates are 
their anti-inflammatory effects which could be attributed to the induction of 
macrophage apoptosis.
Specific Aim: To evaluate the role of decreased infiammation via drug treatment on 
the xenogenic graft material. 
Rationale
Previous studies have shown that Indomethacin and Etidronate exert an 
anti-inflammatory action in the rabbit. Both drugs also have an effect on macrophage
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activity and survival and it was hypothesized that administration of anti-inflammatory 
drugs would reduce the severity o f the inflammatory response towards the Corograft™ 
conduit and the effect of decreased inflammation on the vascular graft could be assessed.
Experimental Design
In this portion of the study, 3 groups of 5 rabbits were treated with saline, Indomethacin 
or Etidronate prior to implantation of the graft, and the drug treatments were continued 
post-operatively. Blood samples were also collected prior to surgery and at sacrifice.
The grafts were harvested at 63 days and analyzed by histology and immunohistology. 
Also, zymograms for MMP activity and a Humoral ELISA were performed on surgery 
and sacrifice serum samples. As both drugs would affect macrophages, a reduction in the 
number of macrophages would be used as an indicator of drug treatment efficacy. CRP 
levels were to be analyzed but proved to be prohibitively expensive and were not done.
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Materials and Methods
Animal Source and Care
Female New Zealand White rabbits (weighing ~3-4kg) were purchased from 
Westem Oregon Rabbit Company (Philomath, OR, USA) and allowed to acclimate for at 
least 7 days before initiating any procedures. Rabbits had access to normal rabbit chow 
and water ad libitum through out the duration of the study. Average room temperature 
was 63°F (17-18°C), with a 12hr day/night cycle and 10-12 air changes/hr. All animals 
appeared clinically normal throughout the 7 day quarantine period and no other pathogen 
testing was done. Baseline blood sample was collected prior to the first injection of drug.
Drug Administration
Each group was pretreated with drug 1-2 hours prior to surgery. This time was 
chosen because previously published studies with indomethacin had shown that the 
arachidonic acid cascade is initiated early on in inflammation and in order to keep 
everything equivalent the same time was used for Etidronate. Dosage: Normal Saline 
(2ml SC), Indomethacin (4mg/kg SC), Etidronate (2.5mg/kg SC). Each drug was 
administered once daily as described for the 63 day period of the study with weekly 
adjustments for weight gain/loss. Normal saline (0.9% Sodium Chloride Irrigation, USP, 
Baxter Healthcare Corporation, Deerfield, IE, USA), Indomethacin, USP (Sigma 
Chemical Co., St. Louis, MO, USA) dissolved in 100% EtOH at 20mg/ml (maximum 
solubility). Etidronate disodium (Didronel® I.V. Infusion, 50mg/ml, MGI Pharma, Inc. 
Minnetonka, MN, USA).
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Preoperative Preparation
Rabbits were sedated with an intramuscular dose of ketamine (50mg/kg), the 
abdominal region shaved, and the rabbit placed in a dorsal recumbent position on a 
heating pad (heating pad was off during the hypothermic phase of the surgery). 
Anesthesia was induced and maintained with 1.5-2% Isoflurane/Oxygen mixture 
administered via a ventilator/anesthesia delivery system (North American Drager, 
Telford, PA, USA or Isotec 4, Surgivet/Anesco Veterinary Surgical Products, Waukesha, 
WI, USA), and the level of isoflurane was adjusted as needed to keep the animal 
sufficiently anesthetized, as evaluated by ear pinch or any evidence of discomfort. The 
chest cavity was not opened allowing for passive, spontaneous ventilation by the animal 
The core temperature was monitored with a rectal temperature probe and 
electrocardiographic leads were attached so the heart rate could be monitored. Icepacks 
were placed around and between the hind-legs and along the lower flanks. An intra­
venous cannula (22 gauge) was introduced into the marginal ear vein and cold (4°C) 
supplemented Lactated Ringer’s Solution was given initiating the hypothermic phase of 
the surgery. The supplemented Lactated Ringer’s solution contained per liter: 20ml 
sodium bicarbonate (84mg/ml and 50mEq/50ml, American Pharmaceutical Partners, Inc. 
Los Angeles, CA, USA), 50ml of 20% mannitol solution and 0.5ml dexamethasone 
sodium phosphate (4mg/ml, American Regent Laboratories, Shirley, NY, USA).
Surgical Protocol
After sterile draping, a midline laparotomy was performed. The skin was 
retracted with traction sutures and the intestines were displaced to the right side and
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wrapped in laparotomy sponges moistened with cold sterile saline. Isolation of the 
abdominal aorta from the surrounding tissues from below the left renal artery to the iliac 
bifurcation was performed meticulously to avoid accidental injury to the inferior vena 
cava and its branches. Care was taken to identify all aortic branches along the entire 
circumference. If feasible, anastomotic sites were planned to avoid cutting of the large 
dorsal aortic branches. Once all dissection was completed, one ml of heparin was 
administered i.v. (1000 USP units/ml, American Pharmaceutical Partners, Inc., Los 
Angeles, CA, USA) and if  necessary, further cooling of the animal was achieved by using 
sterile saline slush applied directly into the abdominal cavity and to the laparotomy 
sponge covering the intestines.
When the rectal temperature of the animal reached 34.5°C, the ice packs and the 
saline slush were removed as the temperature continued to drop without additional 
cooling. The cold supplemented Lactated Ringer’s solution was exchanged for warm 
(37°C). Also, warm packs were placed next to the rabbit under the sterile draping and the 
heating pad under the rabbit was switched on to start the re-warming phase of the 
procedure initiating the re-warming period of the surgery.
Dorsal aortic branches within the previously prepared aortic segment were clipped 
and cut. The aorta was occluded proximally and distally with micro-surgieal vascular 
clamps (MORIA 200/A, Angled, 30mm. Fine Science Tools, Inc. Foster City, CA, USA) 
placed below the left renal artery and above the inferior mesenteric artery. And keeping 
in mind the elastic recoil of the vessel, the aorta was cut approximately 1 cm from each 
clamp to avoid space issues.
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All animals had a Corograft™ (~3-4mm ID x ~4cm minimum) previously re­
hydrated in heparinized saline, implanted into the infrarenal abdominal aorta. An end-to- 
end anastomosis (distal then proximal) was performed with a continuous single 8 /0  
■ Prolene suture (Polypropylene, Ethicon, Inc., Somerville, NJ, USA). Before tying the 
suture for the proximal anastomosis, the distal vascular clamp was removed to flush air 
firom the graft by filling the graft with blood to avoid an air embolism. After tying the 
suture, the proximal vascular clamp was removed and additional 8/0 Prolene suture used 
(as needed) to control anastomotic or graft bleeding.
The intestines were returned to the abdominal cavity and repeatedly lavaged with 
warm sterile saline to achieve appropriate re-warming of the animal. When the rectal 
temperature of the rabbit reached 36.5°C to 37.5°C, the saline was removed and the 
laparotomy closed in two layers with 3/0 Vicryl (Polygalactin 910, Ethicon, Inc., 
Somerville, NJ, USA). The supplemented Lactated Ringer’s solution was discontinued, 
with a total amount of 100-150ml having been administered for both the cold and warm 
solutions. When the animal was re-warmed to physiological temperature (101-104°F/38- 
40°C) and movement was seen in the hind-limbs, the animal was returned to its’ cage.
Rabbits received 0.2ml flunixin meglumine (50mg/ml, Equileve®, Phoenix 
Scientific, Inc., St. Joseph, MO, USA) i.m. as an analgesic immediately after surgery, and 
0.2ml i.m. flunixin meglumine BID for 4 days post-operatively. All rabbits were 
monitored for neurologic or ischemic complications of the hind limbs throughout the 
study. No antibiotic prophylaxis, platelet aggregation inhibitors nor anticoagulants were 
used postoperatively.
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For rabbits in the drug treatment groups, the flunixin dosage (50mg/ml, 
Equileve®, Phoenix Scientific, Inc., St. Joseph, MO, USA) was adjusted to 1.1 mg/kg 
postoperatively and then 1.1 mg/kg BID for the following 3 days.
Sacrifice
The animals were sedated, brought to a full surgical plane of anesthesia, and 
sacrificed before graft isolation. The abdominal incision was re-opened and the graft 
dissected from surrounding tissues. The graft was then excised en-bloc and placed into 
Histo-Choice Tissue Fixative MB (Amresco Inc., Solon, Ohio, USA) for a minimum of 
24hrs before further processing.
Macroscopic Examination
Excess non-adherent tissue/fat was trimmed from the exterior of the graft and the 
graft was photographed with markers placed indicating the suture lines and direction of 
flow. Each graft was evaluated macroscopically for aneurysmatic changes (indicated by 
an area of vessel wall ballooning outwards and being of a greater diameter than the 
originally implanted graft), atherosclerotic lesions, thrombus, or any other obvious 
abnormalities.
Histology
Samples (2-3mm) cut from the center o f the graft were dehydrated and embedded 
in PolyFin wax (Polysciences, Inc., Warrington, Pennsylvania, USA), sectioned at 5pm, 
and collected on slides coated with poly-L-lysine (Sigma Chemical Co., St. Louis, MO,
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USA) or charged slides (Superfrost® plus, VWR Scientific, West Chester, PA, USA). 
Representative sections were stained with hematoxylin and eosin (H&E) for general 
tissue/cellular morphology, Masson’s Trichrome for collagen and Movat’s Pentachrome 
stain for collagen and elastin
Immunohistology
Slides for immunohistology were prepared as above. Representative sections 
were stained for a-smooth muscle cell actin (a smooth muscle cell/myofibroblast 
marker), CD3 (pan-T cell antibody) and RAM 11 (rabbit macrophage-specific antibody). 
Sections stained for a-SMC actin were deparaffinized, treated with 3% H2O2 for 5min to 
remove endogenous peroxidases, rinsed with dH2 0  and blocked with 0.05% Tween-20 
(Sigma Chemical Co., St. Louis, Missouri, USA) in phosphate buffered saline (PBS-T) 
for 30min. The slides were incubated for 30min with the appropriate primary antibody 
diluted in PBS-T, then rinsed with PBS-T. Sections stained for a-actin were incubated 
with Protein A-horseradish peroxidase (Sigma Chemical Co., St. Louis, Missouri, USA),
1:500 dilution in PBS-T for 30min. Sections stained for rabbit macrophages (RAM 11) 
and T cells (CD3) were treated with the components of the LSAB-2 biotin-streptavidin 
amplification kit (DAKO, Carpinteria, California, USA) according to the supplied 
instructions with the incorporation of an avidin/biotin blocking procedure. All 
incubations were carried out in a moist chamber at room temperature. Sections were 
rinsed with PBS-T and developed by the addition of lOOpl of DAB substrate (Sigma Fast 
DAB, Sigma Chemical Co., St. Louis, Missouri, USA) per slide. The development was
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stopped with water and the slides counterstained with H&E or hematoxylin alone. The 
slides were dehydrated, cleared and coverslipped.
Antibody to: Clone Dilution Development Source
a-Smooth Muscle Cell Actin 1A4 1:400 Protein A-HRP Sigma
Rabbit Macrophage RAM 11 1:500 LSAB-2 Dako
T Cell/CD3 Rbt poly 1:50 LSAB-2 Dako
Macrophage Counts
Macrophages are involved in the inflammatory response toward the graft, and the 
numbers present were used as an indirect indicator of disease severity or efficacy o f drug 
treatment. Slides stained with the RAMI 1 antibody were used in this portion of the 
study. Five random lOOX fields were photographed at the junction between graft tissue 
and ablumenal tissue where the majority of the chronic-type inflammatory reaction was 
located. The images were imported into Corel Photo-Paint, gamma adjusted to sharpen 
the color, and counted manually. The number of single macrophages and giant cells were 
counted per image and averaged to obtain the count.
Zymography
MMPs are produced as part of an inflammatory response and are involved in graft 
degeneration, therefore pre- and post-operative serum samples were qualitatively 
evaluated for circulating MMP levels. The conditions present during zymography allow 
for the detection of both the pro-forms and activated MMPs, due to the dissociation of the 
active MMPs from inhibitors or the spontaneous activation of zymogens
Serum samples were electrophoresed on 10% polyacrylamide gels containing 
1 mg/ml Gelatin or Elastin. The samples were diluted 1:10 (v:v) with saline and then 1:1
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with 2X Non-denaturing Sample Buffer (no P-Mercaptoethanol), 20pl loaded onto the 
gel and run at 200 V until completion. The gels were washed 2X 30 min with 2.5%
Triton X-1 0 0 /dH2 0  with agitation, washed 30 min with RT Activation Buffer with 
agitation, and then incubated 0/N  in Activation Buffer at 37°C with agitation 
(Activation buffer 25mM Tris, lOmM CaC^, IpM ZnCb, 50mM NaCl, pH 7.5). Gels 
were stained with coomassie brilliant blue and areas of gelatinolytic or elastolytic activity 
were seen as clear bands against a blue background. MMP activity was confirmed by 
incubating the gels in the presence of Immol/L 1,10-phenantroline (MMP inhibitor) in 
the activation buffer in both the 30 minute wash and ovemight incubation
The MMP profile for all groups did not change between the surgery and sacrifice 
samples within groups, between groups, or between normal diet and cholesterol diet.
Also, no major observable differences in band intensity were seen between surgery and 
sacrifice samples by visual examination.
ELISA for Humoral Response
Dry graft material was lyophilized to a constant weight, suspended in 1% acetic 
acid at a concentration of 1 mg/ml (w/v) and homogenized. The material was diluted to 
~250ug/ml with 0.02M Carbonate buffer (pH 9.6) and lOOul (~25ug/well) of collagen 
was added to each well of a 96-well plate (Falcon PRO-BIND™, Becton Dickinson and 
Company, Franklin Lakes, NJ, USA). The plates were evaporated to dryness ovemight at 
room temperature in a hood. Before use, the plates were washed 4X with PBS-T and 
blocked for 45 min RT (or O/N at 4°C) with lOOul PBS-T/1% BSA per well. The wells 
were then rinsed 4X with PBS-T and serial 2-fold dilutions of serum were plated in
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PBS/1 % BSA (50ul/well in duplicate). The plates were incubated at RT for Ihr and 
washed 4X with PBS-T. Anti-Rabbit IgG-HRP (Monoclonal Anti-Rabbit IgG y-chain 
specific, Clone RG-96, Peroxidase Conjugate A-1949, Sigma-Aldrich Co, St Louis, MO, 
USA) was diluted 1 ;40,000 in PBS-T/1% BSA and 50ul/well was added. The plate was 
incubated 2hrs at RT and washed 4X with PBS-T. OPD substrate (HRP substrate, Dako 
Corporation, Carpinteria, CA, USA) was prepared according to the manufacturers 
instructions (dissolved in room temperature dHaO and 30% H2O2 added) and 50ul of the 
substrate solution was added to each well. The color was allowed to develop 30min at 
room temperature and the reaction stopped by the addition of 50ul of 0.5M H2SO4 to each 
well. The absorbance was read at 490nm in a microplate reader (Opsys MR, Dynex 
Technologies, Chantilly, VA, USA).
Normal rabbit serum was included as the negative control and the values obtained 
used to adjust for serum absorbance. In all cases the CD value from the normal rabbit 
serum was subtracted from the mean valued obtained for the corresponding dilutions of 
the experimental samples. The titer listed is derived from the last well giving a positive 
OD after adjustment. Blank values were obtained from wells incubated with PBS-T/1% 
BSA instead of serum and subtracted from all OD values by the microplate reader 
software.
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Results
Post-operative survival
Twenty-ei^t rabbits were implanted with a graft during this portion of the study. 
Fifteen rabbits made up the three experimental groups, which were treated with Saline, 
Indomethacin or Etidronate. The remaining 13 rabbits were excluded due to 
complications. Four rabbits died during surgery of unknown causes after unclamping the 
abdominal aorta. Four were found dead in their cages on day 0 post-operatively, 3 of 
unknown causes and 1 due to operative complications. Two developed paralysis during 
the post-operative recovery period and were euthanized on day 0. Three additional 
rabbits survived the surgery but developed complications unrelated to the graft and were 
later euthanized. In all cases the implanted grafts were patent upon necropsy.
Drug Treated Groups Macroscopic
No obvious differences were noted between groups. All grafts were patent at explant and 
were surrounded by host tissue with little to no adhesions seen within the abdominal 
cavity. No obvious degeneration or aneurysmic dilation of graft material was seen 
(Figures 10,11 & 12: Saline, Indomethacin & Etidronate Macroscopic).
Histology
Saline Controls 2 Months (Figure 13: Saline Control Histology)
In samples H8542 and H8538, the graft matrix was present in two distinct layers, medial 
more lumenal and adventitial, and some adherent clot was seen in the lumen (post­
mortem). The graft tissue was relatively aeellular with well-preserved matrix although
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Figure 10: Macroscopic images of Saline treated control samples. Grafts are shown in 
both an external (Panel A, C, E, G, and I) and internal view (Panel B, D, F, H and J). All 
grafts were patent at explant and were surrounded by host tissue. No dilation was seen in 
any of the samples. The coagulated blood seen in the lumen of Grafts H8542, H8538 and 
H8540 is from post-mortem clotting, tArrows indicate the suture lines. In all cases, the 
flow of blood is firom left to right.
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Figure 10: Saline sample macroscopic
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Figure 11: Macroscopic images of Indomethacin treated samples. Grafts are shown in 
both an extemal (Panel A, C, E, G, and I) and internal view (Panel B, D, F, H and J). All 
grafts were patent at explant and were surrounded by host tissue. No dilation was seen in 
any of the samples. The coagulated blood seen in the lumen of Grafts H8790 and H8707 
is from post-mortem clotting, tArrows indicate the suture lines. In all cases, the flow of 
blood is from left to right.
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Figure 11: Indomethacin treated macroscopic
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Figure 12: Macroscopic images of Etidronate treated samples. Grafts are shown in both 
an extemal (Panel A, C, E, G, and I) and internal view (Panel B, D, F, H and J). All 
grafts were patent at explant and were surrounded by host tissue. No dilation was seen in 
any of the samples. The coagulated blood seen in the lumen of Grafts H8790 and H8707 
is firom post-mortem clotting, tArrows indicate the suture lines. In all cases, the flow of 
blood is from left to right.
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Figure 12; Etidronate treated macroscopic
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cells were present within the medial (circumferential) layer (WBCs). In samples H8541, 
H8536, and H8540 the graft matrix was very cellular, and the layers were not clearly 
defined due to expansion of the graft material by cells and new matrix material. Grafts 
H8542 and H8538 had a thin ablumenal layer containing mostly loose connective tissue, 
blood vessels and other cells of unknown type. Grafts H8541, H8536, and H8540 had a 
relatively thick ablumenal layer containing blood vessels, adipose tissue as well as 
immature collagen fibrils and collections of inflammatory-type cells (Fig. 13-lA and C). 
No actin staining seen within grafts H8542 and H8538, though ablumenal blood vessels 
were staining. In grafts H8541 and H8536 cells staining for a-SMC actin were present 
for ~ 1/2 of the circumference in both the medial layer and adventitial (longitudinal) layer 
(Fig. 13-2A, C and D), and in ablumenal blood vessels. A few cells staining for actin 
were present in the more superficial medial layer of graft H8540 although blood vessels 
were stained. Macrophages and giant cells were located at the junction between the 
adventitial (longitudinal) layer and the thin ablumenal layer of H8542 and H8538. A 
layer of giant cells separated the medial and adventitial matrix, and formed a ring around 
the graft tissue of H8541 (Fig. 13-lD), and giant cells were also seen within the medial 
layer. Occasional giant cells were also seen adherent to the lumenal surface, and in some 
cases were located in the more superficial portion of the medial layer and caused a 
portion of the graft material to protrude into the lumen. In H8536 and H8540 few giant 
cells were present, mostly located between the medial and the adventitial layers of the 
graft as well as within the ablumenal layer, while single macrophages were present within 
the adventitial tissue. Trichrome staining of H8542 and H8538 showed the majority of 
the collagen was mature and well-preserved (Fig. 13-3B and E). Trichrome of H8541,
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H8536, and H8540 showed that the majority of the collagen present was stained more 
lightly although remnants of more darkly stained mature collagen fibers were still present 
in the adventitial layer (Fig. 13-3A, C and D), and the ablumenal layer contained a loose 
collection of small, lightly stained collagen fibrils. Movats staining of H8542 and H8538 
showed well-preserved elastin in the adventitial (longitudinal) layer, elastic fibrils in the 
medial (circumferential layer), and a complete internal elastic lamina. In H8541 and 
H8536, elastin fibers were not readily apparent and no internal elastic lamina remained.
In H8540 elastin fibers were present within the medial (circumferential) layer but no 
internal elastic lamina remained. All samples had cells staining for CD3 scattered 
throughout the ablumenal layer.
Indomethacin Treated 2 Months (Figure 14: Indomethacin Histology)
Samples from H8535, H8794 and H8792 showed the graft matrix was present in two 
distinct layers, medial and adventitial with some adherent clot present within the lumen 
(post-mortem). The graft tissue was relatively acellular with well-preserved matrix 
although cells were present within the medial layer and appeared to be mostly PMNs 
(Fig. 14-1 A, C and D). The graft matrix of H8790 and H8797 was present in two 
distinct layers with some adherent lumenal clot. In these cases, two-thirds of the graft 
tissue was relatively acellular with well-preserved matrix with PMNs within the medial 
layer (Fig. 14-lB and E), while the remaining third of the graft was re-colonized by host- 
derived cells. Sample H8790 also had PMNs adherent to the lumenal surface. The 
ablumenal layer of samples H8535, H8794, H8790 and H8797 was thin and contained 
mostly loose connective tissue, blood vessels and some other cells of unknown type.
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Figure 13-1; Saline control samples were embedded and 5pm sections were stained with 
H&E for general tissue morphology and cellularity. The graft tissue in H8538 and 
H8542 was relatively acellular with well-preserved matrix while in H8536, H8540 and 
H8541 the graft matrix was very cellular. Collections of inflammatory-type cells were 
seen in H8536 and H8540 (open circles). Macrophages and giant cells in H8541 formed 
a ring around the graft tissue and were seen within the medial layer ( |). In H8536 and 
H8540 few giant cells were present. Scale bar ~100pm.
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Figure 13-1: FI&E stain of Saline control samples
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Figure 13-2: Saline control samples were embedded and 5pm sections were stained for a- 
smooth muscle cell actin, a marker of smooth muscle cells and myofibroblasts. The 
presence of actin-staining cells would indicate the presence of host-derived 
myofibroblasts (involved in healing) or smooth muscle cells (cells normally present in 
blood vessels). No actin staining was seen within H8542 and H8538, in H8541 and 
H8536 cells staining for a-SMC actin were present in both the medial layer and 
adventitial layer, and in G8540 a few cells staining for actin were present in the medial 
layer (open circles). Scale bar ~ 100pm.
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Figure 13-2: Actin stain of Saline control samples
wsm
%.--'4 ,1J p'" '
■ •<'T '■’♦.•**'-1*.- -i
H8536 Saline Control
C ,^  ' *^'
H8538 Saline Control
,- ^  Lh-'
f  , 1( :,.-;’ ■ f  Jift' , '  • ;...>''* ..'̂ '' ’"'r .X'̂ S
H8540 Saline Control 
E
-it"
H8541 Saline Control
H8542 Saline Control
Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.
Figure 13-3: Saline control samples were embedded and 5pm sections were stained by 
Massons Trichrome. This stain is for collagen integrity and organization. The darker 
blue collagen is considered more mature, while lighter staining collagen is considered 
indicative of less mature collagen. The majority of the collagen was mature and well- 
preserved in H8538 and H8542 while in H8536, H8540 and H8541 the majority of the 
collagen present was more lightly stained with remnants of more darkly stained mature 
collagen fibers in the adventitial layer (open circles). Scale bar -lOOpm.
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Figure 13-3: Trichrome stain of Saline control samples
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while graft H8792 had a relatively thicker ablumenal layer containing blood vessels, 
adipose tissue, collagen, few inflammatory-type cells and some macrophages and giant 
cells. In all grafts (H8535, H8794, H8790, H8797, and H8792), macrophages and giant 
cells were located at the junction between the adventitial layer of graft tissue and the 
ablumenal layer (Fig 14-lA to E). In H8790 macrophages and giant cells were seen 
adhering to a portion of the lumen directly apposed to the internal elastic lamina. Actin 
staining was mostly confined to adventitial blood vessels in all samples. In addition to 
blood vessels, H8794 had a few actin staining cells within the graft at the Junction 
between the medial and adventitial layer, and in H8790 several actin staining cells were 
seen within the adventitial layer of the graft (Fig.l4-2B and D). Trichrome showed the 
majority of the collagen was mature and well-preserved in H8535, H8790, H8797 and 
H8792 (Fig 14-3A, B, C and E). In H8790, H8797 and H8792 the medial layer appeared 
expanded, and mature collagen and looser cormective tissue was seen in the ablumenal 
layer. Trichrome of H8794 showed the majority of the collagen was newer, though 
mature collagen was present and may be a remnant from the original graft (Fig, 14-3D). 
Movats showed well-preserved elastin in the adventitial layer, fibrils in the medial layer, 
and a complete internal elastic lamina in H8535, H8797, H8792, while a mostly complete 
internal elastic lamina was seen in H8794 and H8790. Cells staining for CD3 were 
scattered throughout the ablumenal layer in all samples.
Etidronate Treated 1 Month* (Figure 15: Etidronate Histology)
The graft matrix from rabbit H9085 was present in two distinct layers, medial and 
adventitial. The graft tissue was relatively acellular with well-preserved collagen.
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Figure 14-1: Indomethacin samples were embedded and 5 pm sections were stained with 
H&E for general tissue morphology and cellularity. H8535, H8794 and H8792 showed 
the graft tissue was relatively acellular with well-preserved matrix although cells were 
present within the medial layer and appeared to be mostly PMNs (open circles). In 
H8790 and H8797 the majority of the graft tissue was relatively acellular with well- 
preserved matrix with PMNs within the medial layer. Sample H8790 also had PMNs 
adherent to the lumenal surface (i). In H8535, H8794, H8790, H8797, and H8792 
macrophages and giant cells were located at the junction between the adventitial layer of 
graft tissue and the ablumenal layer (t). Scale bar ~ 100pm.
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Figure 14-1: H& E stain o f Indomethacin samples 
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Figure 14-2: Indomethacin samples were embedded and 5 pm sections were stained for a- 
smooth muscle cell actin, a marker of smooth muscle cells and myofibroblasts. The 
presence of actin-staining cells would indicate the presence of host-derived 
myofibroblasts (involved in healing) or smooth muscle cells (cells normally present in 
blood vessels). Actin staining was mostly confined to adventitial blood vessels in all 
samples. H8794 had a few actin staining cells within the graft at the junction between the 
medial and adventitial layer, and in H8790 several actin staining cells were seen within 
the adventitial layer of the graft (t). Scale bar ~100pm.
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Figure 14-2: Actin stain of Indomethacin samples
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Figure 14-3: Indomethacin samples were embedded and 5pm sections were stained by 
Massons Trichrome. This stain is for collagen integrity and organization. The darker 
blue collagen is considered more mature, while lighter staining collagen is considered 
indicative of less mature collagen. In H8535, H8790, H8797 and H8792 the majority of 
the collagen was mature and well-preserved. In H8790, H8797 and H8792 the medial 
layer appeared expanded (open circles) while in H8794 the majority of the collagen was 
newer (open circle), though mature collagen was present and may be a remnant from the 
original graft ( |) . Scale bar -lOOpm.
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Figure 14-3: Trichrome stain of Indomethacin samples
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although cells were present within the medial layer and appeared to be mostly PMNs 
(Fig. 15-lC). A relatively thicker ablumenal layer was present containing blood vessels, 
adipose tissue, collagen, numerous inflammatory-type cells and numerous macrophages 
and many giant cells that were located at the junction between the adventitial layer of 
graft tissue and the ablumenal layer as well as within this layer (Fig. 15-lC). No actin 
staining cells were seen within the adventitial layer of the graft, and adventitial blood 
vessels were staining (Fig. 15-2C). Trichrome showed that the medial layer appeared 
expanded, mature collagen and looser connective tissue were seen in the adventitial layer 
and ablumenal layers. Movats showed well-preserved elastin in a majority of the 
adventitial layer, fibrils in the medial layer, and a complete internal elastic lamina. 
Occasional cells staining for CD3 were scattered throughout the ablumenal layer.
Etidronate Treated 2 Months (Figure 15: Etidronate Histology)
The graft matrix of H9086, H9087 and H9084 was present in two distinct layers, medial 
and adventitial. The graft tissue was relatively cellular with well-preserved collagen, and 
the cells present within the medial layer appear to be mostly PMNs in H9086, mostly 
PMNs and macrophages with a few fibroblastic-type cells in H9087, while in H9084 
were PMNs, macrophages with the majority of this layer repopulated with fibroblastic 
type cells (Fig. 15-lB, D and E). In H9081 the graft matrix was present in two distinct 
layers, medial and adventitial but was relatively acellular with well-preserved matrix 
although cells are present within the medial layer and appear to be mostly PMNs (Fig. 
15-lA). All samples had an ablumenal layer of varying thickness containing blood 
vessels, adipose tissue, collagen, few inflammatory-type cells and macrophages (Fig. 15-
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lA, B, D and E). In H9086 and H9087 few macrophages and giant cells were located at 
the junction between the adventitial layer o f graft tissue and the ablumenal layer, and 
H9087 had more giant cells present within the ablumenal layer. Sample H9084 had 
many giant cells and single macrophages located at the junction of the adventitial and 
ablumenal layer, with more giant cells present within the ablumenal layer (Fig. 15-lB). 
H9081 had few macrophages and many giant cells giant cells at the junction of the 
adventitial and ablumenal layer as well as deeper in this tissue layer. Macrophage giant 
cells were also seen adherent to the lumenal surface (Fig. 15-3A). In addition to actin 
staining seen in the ablumenal tissue of all samples, H9086 had several actin staining 
cells sparsely distributed within the adventitial layer of the graft (Fig. 15-2D). H9087 
had numerous actin staining cells distributed within the medial and adventitial layer of 
the graft and in the ablumenal tissue (Fig. 15-2E). H9084 had several small collections 
of actin staining cells that were distributed within the medial and adventitial layers and a 
larger patch present on the lumenal surface of the graft (Fig. 15-2B). Although not a 
complete re-population, actin staining cells were seen within the medial layer at the 
junction with the adventitial layer of the graft and in the adventitia of H9081 (Fig. 15- 
2A). In all samples, trichrome staining showed the majority of the collagen was mature 
and well-preserved, the medial layer appeared expanded, and mature collagen and looser 
connective tissue were seen in the ablumenal layer (Fig. 15-3A to E ) . Movats showed 
well-preserved elastin in a majority of the adventitial (longitudinal) layer, fibrils in the 
medial (circumferential) layer, with a complete intemal elastic lamina in H9086, or an 
occasional fragment of intemal elastic lamina in H9087. In H9084 and H9081, Movats 
showed well-preserved elastin in a majority of the adventitial layer, few fibrils in the
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medial (circumferential) layer, and no intemal elastic lamina (H9084) or a fragmented 
intemal elastic lamina (H9081). Occasional cells staining for CD3 were scattered 
throughout the ablumenal layer.
Macrophage Counts
The saline control group had a mean of 44.8 macrophages present, while this number was 
reduced for the dmg-treated groups. The Indomethacin group had a mean of 14.68 
macrophages, and the Etidronate group had a mean of 13.5 macrophages (without 9085 
25 day) and 20.3 macrophages per lOOX field (with 9085). This corresponds to a 67.2% 
reduction in mean number of macrophages present in the Indomethacin samples, and a 
69.95% reduction in mean number of macrophages in the Etidronate group (no 9085). 
The differences between the saline controls and the dmg treatment samples are 
statistically significant by Dunnett multiple comparison tests (Indomethacin P<0.01, 
Etidronate P<0.05)
Zymography
The MMP profiles did not change between the surgery and sacrifice samples and no 
major observable differences in band intensity were seen between surgery and sacrifice. 
However, zymograms showed a difference in the MMP profile between control and drug 
treated samples, seen as an absence of the higher mw MMPs and several minor bands in 
both the Indomethacin and Etidronate groups. The Etidronate serum samples showed 
nearly a complete absence of MMP activity, while the activity was very reduced in the 
Indomethacin samples. Development in the presence of 1,10-phenanthroIine (MMP
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Figure 15-1: Etidronate samples were embedded and 5pm sections were stained with 
H&E for general tissue morphology and cellularity. H9085 was relatively acellular with 
well-preserved collagen, although cells were present within the medial layer and 
appeared to be mostly PMNs (open circle). Numerous inflammatory-type cells (t), 
macrophages and giant cells (J.) were located at the junction between the adventitial layer 
of graft tissue and the ablumenal layer and within this layer. H9086, H9087 and H9084 
was relatively cellular with well-preserved collagen, and the cells present within the 
medial layer appear to be mostly PMNs in H9086, PMNs and macrophages with a few 
fibroblastic-type cells in H9087, H9084 were PMNs, macrophages and fibroblastic type 
cells (open circle). H9081 the graft matrix was relatively acellular with well-preserved 
matrix although the cells present within the medial layer appear to be PMNs (open 
circles). H9086 and H9087 few macrophages and giant cells were located at the junction 
between the graft tissue and the ablumenal layer, and H9087 had more giant cells present 
within the ablumenal layer. H9084 had many giant cells and single macrophages located 
at the junction of the graft and ablumenal layer. H9081 had few macrophages and many 
giant cells giant cells at the junction of the graft and ablumenal layer with macrophage 
giant cells adherent to the lumenal surface. Fewer inflammatory-type cells (t)  were 
present in H9081, H9086, H9087 and H9084 compared to H9085. Scale bar -lOOpm.
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Figure 15-1: FI&E stain of Etidronate samples
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Figure 15-2: Etidronate samples were embedded and 5pm sections were stained for a- 
smooth muscle cell actin, a marker of smooth muscle cells and myofibroblasts. The 
presence of actin-staining cells would indicate the presence of host-derived 
myofibroblasts (involved in healing) or smooth muscle cells (cells normally present in 
blood vessels). In H9085 no actin staining was seen within the graft. H9086 had several 
actin staining cells sparsely distributed within the adventitial layer of the graft. H9087 
had numerous actin staining cells distributed within the medial and adventitial layers of 
the graft. H9084 had several small collections of actin staining cells within the medial 
and adventitia layers with a larger patch present on the lumenal surface (f). Actin 
staining cells were seen within the medial layer at the junction with the adventitial layer 
of the graft of H9081. Scale bar ~100pm.
177
Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.
Figure 15-2; Actin stain of Etidronate samples
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Figure 15-3: Etidronate samples were embedded and 5pm sections were stained by 
Massons Trichrome. This stain is for collagen integrity and organization. The darker 
blue collagen is considered more mature, while lighter staining collagen is considered 
indicative of less mature collagen. In all samples. Trichrome staining showed the 
majority o f the collagen was mature and well-preserved with newer collagen present 
(open circles). Scale bar ~100pm.
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Figure 15-3: Trichrome stain of Etidronate samples
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inhibitor) indicated that the majority of the gelatinolytic activity was due to MMPs, with 
very little due to other proteases (data not shown). No elastolytic activity was observed 
in any of the samples at 4 days.
Humoral ELISA
Statistical analysis o f the ELISA titer log values indicated that there were no significant 
differences between surgery and sacrifice in the saline treated groups (paired two-tail T 
test). Statistically significant differences (paired two-tailed T test) were seen between the 
surgery and sacrifice samples for Indomethacin (P<0.0001) and Etidronate (P = 0.0054). 
However no significant differences were seen between the control and drug-treated 
samples at sacrifice.
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Table 8: Macrophage counts from Drug treatment samples.
Slides stained for RAMI 1 were used to generate the counts. Five high-power fields were 
photographed at the junction of the graft material and the ablumenal host tissue. The 
macrophages were counted, and the number averaged to obtain the given values. Values 
are Mean ± SEM.
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Table 8: Macrophage Counts - Drug Treatment
Rabbit # Average # of Mean # of % Reduction in
Macrophages Macrophages^ # Macrophage
Control
H8541 2 month 56.2
H8542 2 month 40.2
H8538 2 month 46.8 44.8±6.4 N/A
H8536 2 month 22.8
H8540 2 month 57.8
Indomethacin
H8535 2 month 16.8
H8794 2 month 18.8
H8790 2 month 10.6 14.6+2.6 67.2%
H8797 2 month 20.6
H8792 2 month 6.6
Etidronate
H9085* 1 month 12.6
H9086 2 month 47.4
H9087 2 month 13.8 22.15+8.6 50.5%
H9084 2 month 18.0 (20.3±6.9*) (54.6%*)
H9081 2 month 9.4
Indicates numbers calculated with the 1 month sample
"Mean ± SEM
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Figure 16: To analyze differences in MMP presence or expression between surgery and 
sacrifice samples, equivalent amounts o f serum were electrophoresed on 10% acrylamide 
gels containing 1% gelatin. The gels were run to completion, washed to remove SDS, 
and incubated in activation buffer (with and without MMP inhibitor) for the appropriate 
time. Gels were stained with coomassie brilliant blue, and active bands appear as clear 
bands on a blue background. No observable differences were seen within or between 
groups, or between diet types for all rabbits.
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Figure 16: Zymograms of Normal, Indomethacin and Etidronate samples
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Table 9; Serum samples were eollected and stored at -60°C until all had been collected 
then the humoral response toward the graft material was quantified by the humoral 
ELISA. Each sample was analyzed in duplicate, with each plate containing an internal 
blank. All readings were averaged, adjusted for normal rabbit serum OD, and the 
reciprocal given.
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Table 9: ELISA - Drag Treatment
Rabbit # Titer @ 
Surgery
Titer @ 
Sacrifice
Saline controls
8541 160 1280
8542 2560 320
8538 640 160
8536 320 2560
8540 80 2560
Indomethacin treated
8535 2 0 320
8792 2 0 320
8790 40 320
8797 40 320
8794 80 320
Etidronate treated
9086 2 0 80
9087 2 0 10240
9084 2 0 2560
9085* 2 0 2560
9081 2 0 2560
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Figure 17: The log of the ELISA titers were plotted to graphically show the differences 
between the humoral response to the graft material at surgery and then at sacrifice. In all 
cases except 2 (saline H8542 and H8538), there was an increased humoral response to the 
graft between surgery and sacrifice. Statistically significant differences (paired two- 
tailed T test) were seen between the surgery and sacrifice samples for Indomethacin 
(P<0.0001) and Etidronate (P = 0.0054). However no significant differences were seen 
between the control and drug-treated samples at sacrifiee.
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Figure 17: ELISA of Control, Indomethacin and Etidronate Samples
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189
Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.
Table 10: Compiled Results of Saline, Indomethacin and Etidronate treated samples. The 
histology, immunohistology, macrophage counts, and ELISA information are 
summarized to provide an overview of the results.
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Table 10: Compiled Results of Drug Treatment Samples
Animal # Graft
Cellularity
Actin Collagen
Remodel
Macrophage
Presence
Tissue
Destruction
Humoral
Response
Saline control
H8536 ++++ ++++ +++ +++ - +++
H8538 + - + +++ - +
H8540 + + + ++ - +++
H8541 +++ +++ ++++ ++ + + + +
H8542 - - + + - + +
Indomethacin treated
H8535 - - -/+ + - ++
H8790 -/+ -/+ -/+ + - ++
H8792 - -/+ + + - ++
H8794 -/+ + +++ + - ++
H8797 ++ - ++ + - ++
Etidronate treated
H9081 + ++ ++ ++ - +++
H9084 ++ + + + - +++
H9085 -/+ - + + - +++
H9086 + + + + - +/-
H9087 +++ +++ ++ + - ++++
Graft Cellularity -(0%) —̂ ++++ (100%) re-colonization of graft material by host cells. 
Actin -(0%) —> ++++ (100%) recolonization of graft media by actin-positive cells. 
Collagen Remodel -(0%) —> ++++ (100%) newly produced collagen vs. mature. 
Macrophage Presence -(few macrophages) —> ++++ (40-50) avg. # macrophages. 
Tissue Destruction -(0%) ++++ (100%) destruction of original graft material.
Humoral Response -(0%) ++++ (100%) of maximum response, rated relative to the
highest response seen for all grafts.
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Discussion
Reduce Inflammation: Effect of Anti-Inflammatory Drugs
Observations from the previous portion of the study suggest that these rabbits 
developed a chronic inflammatory-type response toward the graft material. A common 
finding in the previous chapter was the constant presence of macrophages and giant cells 
in the ablumenal tissue, suggesting a chronic-type inflammatory reaction. This led to the 
use of this model of grafting to evaluate additional treatment strategies to enhance the 
durability of graft material in vivo. As macrophages are important players in 
inflammation and have been implicated in graft degeneration, the drugs chosen for this 
portion of the study had previously been shown in published studies to reduce 
macrophages in rabbit models of atherosclerosis, and it was speculated that they might 
also improve the durability of the grafts in this study.
Macroscopically, none of the grafts in the 3 groups showed any evidence of 
aneurysm or dilation which is in direct contrast to samples fi-om chapter 2. In the 
previous chapter, little dilation was seen at 2 months and was increased at 4 months, 
while in this portion of the study two months may be insufficient for graft dilation to 
occur. In nearly ever graft in this study, the graft matrix was either well-preserved or had 
undergone some remodeling, implying that little collagen degeneration had occurred 
compared to the 2 ,4  and 6  month samples in which more collagen remodeling had 
occurred. This may be due to differences in the physiology of the animals between the 
two studies or differences in the graft material. Further studies to explore these 
differences could include longer studies incorporating these drugs to evaluate the drug 
effects on the development of dilation, as well as correlating changes in graft matrix
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degeneration with dilation or aneurysm development by quantifying the collagen and 
elastin content of the graft.
Indomethacin
Rabbits were treated with indomethacin prior to and after graft implantation and 
on explant at 2 months the grafts were found to be incorporated into the host. The grafts 
were covered with host-derived tissue with little evidence fibrosis. Microscopic analysis 
of the samples showed the graft material was minimally re-colonized by host-derived 
cells when compared to controls. The rabbits treated with Indomethacin showed a 
marked decrease in the number of macrophages present with the graft tissue compared to 
the saline controls with no incidence of graft degeneration.
Published studies suggest that the reduction in the number of macrophages could 
be due to the effect of Indomethacin on the arachidonic acid cascade activated during 
inflammation. Indomethacin inhibits the initial phospholipase cleavage of membrane 
phospholipids to arachidonic acid reducing the response, and also acts further down the 
cascade by directly activating peroxisome proliferator-activated receptors (PP AR) a  and 
Y which are down-regulated by LTB4 and PGJ2 respectively during inflammation. This 
activation results in the apoptosis of activated (PPARa) and un-activated (PPARa and y) 
macrophages The use of PPAR agonists would allow for this mechanism to be 
explored, allowing for the inhibition o f macrophages without affecting the remainder of 
the inflammatory response, and evaluating the effect on graft durability.
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Etidronate
The grafts recovered at 2 months treated with Etidronate before and after surgery 
also were found to be incorporated into the host. The grafts were covered with host- 
derived tissue with little evidence fibrosis. Microscopic analysis of the samples showed 
the graft material was re-colonized by host-derived cells to a greater extent that 
Indomethacin treated samples. The rabbits treated with Etidronate also showed a marked 
decrease in the number of macrophages present with the graft tissue compared to the 
saline controls with no incidence of graft degeneration. Published studies suggest this 
reduction may be due to the induction of apoptosis in these cells by the drug This 
mechanism could be further explored by the use of statins in grafted animals, which 
should also reduce macrophages.
Zymography
No reduction in circulating serum MMPs was seen within groups when 
Indomethacin or Etidronate treated samples from surgery and sacrifice were compared. 
This may be due to the methodology which may not be sensitive enough to detect the 
differences. Another possibility could be that since the graft is a small part of the 
vasculature and the MMPs secreted within the area of the graft are diluted in the blood 
stream the differences can not be detected. However, in-depth analysis of the graft 
samples for MMPs with more sensitive techniques such as immunohistology or western 
blotting could reveal differences not seen with zymography.
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Humoral response
No significant differences were seen in the humoral response between controls 
and drug treated samples at sacrifice. In all cases the response was increased suggesting 
the graft material elicits a response and this may be due to eomponents of the xenogenic 
extracellular matrix (such as collagen) stimulating a response. Extracellular matrix 
components are known to elicit an immune response and the macrophages and giant 
cells may be presenting graft antigens to T and B cells resulting in the immune response 
toward the graft material.
However what we are seeing is a snap-shot at a single time-point and does not 
indicate what the response has been previously or will be in the future. A better way to 
monitor the humoral response would be to collect multiple samples throughout the 
duration of the study and to follow the trend of the response. This would more accurately 
show what is happening over time.
Conclusions
No aneurysm development was seen in any of the drug study samples (controls 
and treated) but 2  months may not be enough time to develop aneurysm under 
normocholesterolemic conditions. Both Indomethacin and Etidronate reduced the overall 
macrophage number present when compared to saline controls, but since macrophages, 
giant cells and T-cells are still present this suggests that there is still and ongoing 
response. No statistically significant difference was seen in the humoral response in any 
of the groups and the zymography data was inconclusive.
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Taken together these data suggest that anti-inflammatory treatments affect the 
host response toward the graft material by reducing the presence of macrophages, but 
other mechanism could also be responsible. Also, this suggests that the use o f adjunct 
anti-inflammatory treatments after bypass grafting could improve the long-term 
durability and survival of grafts in the clinical setting by reducing cells involved in graft 
failure. These data could also lead to further modifications of the original graft material 
during production, leading to a product with superior resistance to inflammatory 
degradation. However, care must be taken not to suppress the inflammatory response 
excessively, as this could lead to detrimental effects on the normal healing process.
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Appendix
Figure 18: This figure illustrates the effects of indomethacin on inflammation as well as 
the possible mechanisms by which inflammation, macrophages and MMPs are regulated. 
Generated from references 25.26,28,52,58-65
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Figure 18: Indomethacin Effects on Inflammation
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Figure 19: The effects of both bisphosphonate and amino-bisphosphonates on cell 
survival are illustrated. Amino-bisphosphonates act via inhibition of mevalonate 
pathway, while bisphosphonates (Etidronate is a member of this group) act on the MST 
kinases directly, both of which result in the induction of cellular apoptosis Adapted 
from references 36>66.67,68
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Figure 19: Bisphosphonate Action
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Table 11; Surgery and sacrifice data for all rabbits in this study are complied in this 
table. The weights at surgery and sacrifice are listed, the operative weight was not 
significantly different between groups, while the weight at sacrifice was increased in the 
saline and indomethacin groups. The average graft length and cross-clamp time did not 
vary significantly between groups.
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Table 11: Surgery and Graft Data
Rabbit
#
Surgery
Date
Weight @ 
Surgery
Graft X-Ciamp 
Length (min)
Graft# Date
Opened
Sacrifice
Date
Weight @ 
Sacrifice
Saline Treated
HSS42 03/12/03 3.6kg 4.2cm 27.5 2B0110-03002 03/05/03 05/14/03 4.88kg
H8541 03/12/03 3.4 4 25 2B0110-03015 03/12/03 05/14/03 4.66
H8S38 03/14/03 3.75 4 27 2B0110-03013 03/14/03 05/16/03 4.54
H8536 03/21/03 3.86 4 31.5 2B0110-03022 03/20/03 05/23/03 4.88
H8540 03/23/03 3.6 4 25 2B0110-03019 03/21/03 05/26/03 4.5
Mean ± Std Dev 3.64±0.2 4.04±0.2 27.2±2.7 4.69±0.2
Indomethacin Treated
H8535 03/25/03 3.86kq 4.1 23.2 2B0110-03022 03/05/03 05/27/03 4.89kg
H8794 04/01/03 3.29 4 26.5 2B0110-03013 03/14/03 06/03/03 3.97
H8790 04/04/03 3.86 4 24.75 2B0110-03014 03/21/03 06/06/03 4.5
H8797 04/07/03 3.97 3.9 21.4 2B0110-03022 03/20/03 06/09/03 4.3
H8792 04/14/03 3.97 4 24 2B0110-03021 04/08/03 06/16/03 4.65
Mean ± Std Dev 3.79±0.3 4±0.1 23.9±1.9 4.46±0.4
Etidronate Treated
H9085" 05/05/03 3.75kq 3.9 24 2B0110-03022 05/05/03 05/30/03 3.6kg
H9086 04/28/03 3.86 3.9 24.2 2B0110-03002 03/05/03 06/30/03 3.4
H9087 04/29/03 3.86 4 24 2B0110-03015 03/12/03 07/01/03 3.4
H9084 04/30/03 3.75 4 21 2B0110-03013 03/14/03 07/02/03 3.5
H9081 05/06/03 4.4 3.9 29 280110-03021 04/08/03 07/8/03 3.5
Mean ± Std Dev 3.97±0.3 3.95±0.1 24.5±3.3 3.48±0.1
^Sacrificed at 25 days
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Table 12; The sacrifice dates are listed for all rabbits, as is the duration of the graft 
implantation. All rabbits were sacrificed at 63 days except for H9085 which was 
sacrificed at 25 days.
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Table 12: Sacrifice Dates
Rabbit # Cause of Death Duration
Saline Control
H8542 Sacrificed 63 days
H8541 Sacrificed 63 days
H8538 Sacrificed 63 days
H8536 Sacrificed 63 days
H8540 Sacrificed 63 days
indomethacin Treatment
H8535 Sacrificed 63 days
H8794 Sacrificed 63 days
H8790 Sacrificed 63 days
H8797 Sacrificed 63 days
H8792 Sacrificed 63 days
Etidronate Treatment
H9085 Euthanized 25 days*
H9086 Sacrificed 63 days
H9087 Sacrificed 63 days
H9084 Sacrificed 63 days
H9081 Sacrificed 63 days
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